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As one of the adaptor proteins, ankyrin rich membrane spanning protein 
(ARMS/Kidins220) is highly expressed in the nervous system, such as the hippocampus, 
olfactory burb, and motor neurons in the spiral cord. Generally, ARMS/Kidins220 
interacts with the neurotrophin, ephrin, vascular endothelial growth factor (VEGF) and 
glutamate receptors, which have many essential roles in the nervous system such as 
neuronal survival, neuronal differentiation, dendrites and synapse developments. Recent 
studies have reported that this protein yields sustained signal of the mitogen-activated 
protein kinase (MAPK) via the CrkL-C3G complex and Rap1, which are both highly  




in controlling cell cycle.  
Cell proliferation is tightly controlled by cyclins and cyclin-dependent kinase 
(CDKs) in G1, S, M, and G2 phases. First, we observed that knockdown of 
ARMS/Kidins220 inhibited mouse neuroblastoma cell proliferation and resulted in a 
slowdown of cell cycle during G1 phase by reductions of cyclin D1 and CDK4. In 
addition, these decrease in cyclin D1 and CDK4 protein levels cause a subsequent 
reduction of pRb hyperphosphorylation which occurs at the G1/S phase transition. 
Moreover, we observed an upregulation of p21, a CDK4 inhibitor, with downregulation 
of ARMS/Kidins220. Taken together, these data suggest that p21 inhibits the kinase 
activity of cyclin D1-CDK4 and prevents the hyperphosphorylation of pRb, resulting in 
down regulation of cell cycle progression. Therefore, we report that the low 
ARMS/Kidins220 has a role as a signaling mediator to regulate neuroblastoma 
proliferation and could be worked as a potential oncogene.  
Human mesenchymal stem cells (hMSCs) can self-renew and differentiate into 
multiple cell types, which make them suitable for use in tissue engineering and cell 
therapy. However, their clinical application is hindered by the need for in vitro culture 
with growth factors in order for their expansion to reach therapeutically useful levels. 
Moreover, hMSCs consist of a heterogeneous population that exhibits variable 
morphology, a limited capacity for self-renewal, and inefficient differentiation. Thus, 
obtaining purified hMSCs with high potential is an important step toward increasing the 
efficiency of stem cell therapy.  
For the purpose of flow-based identification of hMSC subpopulations, optimally 
designed microfluidic chips were developed based on the hydrodynamic filtration (HDF) 
principle. In these chips, hydrodynamic effects for passive separation are combined with 




from complete analysis of laminar flow for flow fraction and complicated networks of 
main and multi-branched channels, which were validated for microfluidic cell sorting by 
HDF to fractionate hMSCs into three size-dependent subpopulations: small rapidly self-
renewing (RS, < 25 µm); medium spindle-shaped (SS, 25–40 µm); and large flattened 
(FL, > 40 µm) cells. In our HDF chip, a virtual cut-off width (WC) boundary causes 
hMSCs to migrate to sidewalls, whereby they enter branch channels in response to 
specific ratios between main and side flows. Our results showed continuous and rapid 
sorting of hMSCs into three subpopulations with highly efficient recovery (>86%) and 
complete purity rates, and without damage to cells.  
Analysis of surface marker expression revealed that RS and SS cells showed high 
levels of CD73, CD90, and CD105, whereas FL cells did not express CD73. 
Subsequently, to compare the multipotency of sorted cells, each subpopulation was 
induced to undergo adipogenic, osteogenic, and Schwann cell (SC) differentiation. 
Phenotypic and gene marker expression analyses of differentiation indicated that sorted 
RS and SS subpopulations showed higher potential for adipogenic, osteogenic, and 
Schwann cell differentiation than the FL subpopulation. Moreover, RS and SS cells 
displayed significantly increased expression of SC markers and growth factors such as 
hepatocyte growth factor (HGF) and vascular endothelial growth factor (VEGF).  
Therefore, our results indicate that the microfluidic chip successfully sorted 
hMSCs based on size and target cells with high multilineage potentials were obtained 
from hMSCs.  
 
Keywords: ARMS/Kidisn220, cell cycle, cyclin D1, cyclin-dependent kinase 4, p21, 
Human mesenchymal stem cells, Microfluidic sorting chip, Hydrodynamic filtration,   
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І. Regulation of cell cycle  
Cell cycle can be subdivided into four different phases, referred to as G1- 
(gap-1/growth), S- (DNA synthesis), G2- (gap-2) and M-phase (mitosis) (Bertoli et 
al., 2013) (Fig. 1). Altogether, G1-, S- and G2-phase represent the interphase, which 
prepares the cell for division during mitosis. In G1-phase, the cell integrates intra- 
and extracellular signals and decides to continue replication or to pause cell cycle 
progression. When pausing, cells can either undergo apoptosis or enter a quiescent, 
nondividing state (GO) which still allows a re-entry into cell cycle (Fig. 1). 
A complex network of regulatory proteins controls cell cycle at several 
restriction points. An initial restriction point determines if a cell in G1-phase enters 
S-phase. Furthermore, other DNA structure checkpoints prevent the cell from phase 
transition and cell division if DNA is damaged or imperfectly replicated. The 
importance of these checkpoint mechanisms becomes apparent through analysis of 
mutations of the required regulatory proteins during oncogenesis (Massagué, 2004). 
Numerous proteins that regulate transcription of specific genes control the correct 
transition throughout the different cell cycle phases. For all cell types, the activation 
of cyclin-dependent kinases (CDKs) is an essential prerequisite for cell cycle 




and fulfill core functions in cell cycle regulation when activated by binding a cyclin 
subunit (Manning et al., 2002). Each cyclin interacts one or two different CDKs and 
vice versa. The different stages of the cell cycle are associated with an oscillating 
appearance of different cyclins. D-type cyclins are active in G1-phase, E- and A-
type cyclins in S-phase and B- and A-type cyclins in M-phase (Murray, 2004). 
Ubiquitination by the Skp1-cullin-F-box protein (SCF)-complex depends on 
phosphorylation (P) by upstream kinases like GSK3β (glycogen synthase kinase-3 
β). In G1-phase, the pocket proteins, retinoblastoma protein (RB), retinoblastoma-
like proteins 1, or -2 (RBL1 or RBL2) bind and inhibit transcription factors of the 
E2F family, which control gene transcription. After cyclin D/CDK4/6 dependent 
phosphorylation, pocket proteins release E2F transcription factors to initiate gene 
transcription for cell cycle progression to S-phase (Massagué, 2004). Oscillation of 
cyclin ensures correct progression to the next cell cycle stage while preventing 
reverse progression. For proper regulation of cyclin/CDK complexes during cell 
cycle progression, cyclins have to be inactivated, which is assured by rapid protein 
degradation via the ubiquitin-proteasome system. Upon selective phosphorylation, 
cyclins are recognized by the SCF E3 ubiquitin ligase and are subsequently 
ubiquitinated for 26S proteasomal degradation. Alternatively, without prior 
phosphorylation, cyclins can be recognized by another E3 ligase named anaphase-
promoting complex (APC) (Vodermaier, 2004) (Fig. 2).  
Since the SCF complex is active throughout the entire cell cycle, and the 
APC is activated at the onset of the anaphase, the complexes function in different 
stages of cell cycle. G1-phase cyclins therefore are ubiquitinated by the SCF 




addition to regulation of cyclin D and E protein stability, cyclin/CDK activity is 
additionally controlled by CDK inhibitors (CKIs) at the transition from G1- to S-
phase. Based on their structure and specificity, CKIs are divided into two families. 
The INK4 family (inhibitors of CDK4) consists of p16INK4a, p15INK4b, 
p18INK4c, and p19INK4d, which specifically bind to CDK4 and CDK6 and 
disturb their interaction with the respective D-type cyclins (Sherr and Roberts, 
1999). In contrast, CKIs of the Cip/Kip1 family, comprising p21Cip1/Waf1 (also 
called cyclin-dependent kinase inhibitor 1A, CDKN1A), p27Kip1 (CDKN1B) and 
p57Kip2 (CDKN1C), are characterized by their binding to CDKs and cyclins. 
Cip/Kip1 CKIs regulate the activity of cyclin D-, E-, A- and B-/CDK complexes 
(Sherr and Roberts, 1999; Besson et al., 2008). Heterozygous p27Kip1 knockout 
mice showed increased body size and organ hyperplasia, whereas a p21Cip1/Waf1 
knockout resulted in deregulation of DNA-damage dependent G1-phase cell cycle 
arrest (Besson et al., 2008). The knockout of p57Kip2 led to organ hyperplasia due 
to a defective cell cycle exit (Zhang et al., 1997). Cip/Kip proteins are intrinsically 
unstructured and only adopt specific conformations after binding to other proteins 
(Lacy et al., 2004), allowing for a broad range of binding partners. 
In addition to blocking G1-S-phase progression, CKIs of the Kip/Cip family 
fulfill additional functions in the regulation of gene transcription, apoptosis, cell 
motility, and differentiation (Besson et al., 2008). Post-translational modifications, 
especially phosphorylation, are thought to modulate protein functions by 
influencing stability, binding partners affinity or subcellular localization (Borriello 




Figure 1. Overview of cell cycle. The mammalian cell cycle is divided into four 
different phases. In G1-phase, the cell can decide to enter a quiescent state (GO) or 
to prepare entering S-phase for DNA replication and subsequent cell division. In 




Figure 2. Major components of cell cycle regulation. Different cyclin/CDK-
complexes are assembled in different phases of cell cycle and function as regulators 
of cell cycle progression by phosphorylation of various proteins (Murray, 2004). 
Upon differentiation or lacking growth signals in G1-phase, the activity of 
cyclin/CDK complexes is inhibited by CKIs (cyclin-dependent kinase inhibitors) of 
the INK4 (p15, p16, p18, p19) or Cip/Kip (p21Cip1, p27Kip1, p57Kip2) family 
(Sherr and Roberts, 1999; Besson et al., 2008). On the other hand, cyclin/CDK-
complexes are regulated by rapid degradation of the cyclin component via the 
ubiquitin proteasome pathway and being targeted by E3 ubiquitin ligases of the 
APC- (Anaphase promoting complex) or SCF-type (Skp1-cullin-F-box protein) 




phase is to prepare the cell for DNA replication and subsequent cell division. 
Therefore, during G1-phase the transcription of genes encoding for proteins that are  
required for cell cycle progression is induced. One of the proteins regulating gene 
transcription in G1-S-phase is the tumor suppressor protein RB. The so-called 
pocket proteins RB, RBL1 (also named p107) and RBL2 (known as p130) inhibit 
E2F transcription factors due to their binding. In all phases of cell cycle including 
Go, E2F-dependent gene transcription is inhibited, until cell cycle reaches late G1-
phase. Pocket proteins are then phosphorylated by phase specific D-type 
cyclin/CDK4/6 complexes and release the E2F transcription factors to induce gene 
transcription (Bertoli et al., 2013). A complex network of many different proteins 
thus regulates cell cycle progression. A functional disturbance of one or several of 
these proteins can deregulate accurate cell cycle progression and potentially 
promote developmental alterations or severe diseases, such as cancer.  
II. Ankyrin-rich membrane spanning protein (ARMS/Kidins220) 
ARMS/Kidins220 was initially identified as a substrate for protein kinase D 
(PKD) in neural cells (Iglesias et al., 2000) and has been independently 
characterized as a downstream target of the signaling mediated by neurotrophins 
and ephrins (Kong et al., 2001). This protein is an integral membrane protein with 
four transmembrane segments and N- and C-terminal tails that are both exposed to 
the cytoplasm (Fig. 3). Sequence analysis of ARMS/Kidins220 revealed the 
presence of numerous domains that mediate protein–protein interactions. The N-
terminus of ARMS/Kidins220 contains 11 ankyrin repeats, which form a concave 




Figure 3. The Structure of ARMS/Kidins220 with multiple protein-protein 
interaction sites. ARMS/Kidins220 has different domains and sites of post-
translational modifications. Also shown are the molecular partners identified to date, 
the cellular events are triggered by their binding to ARMS/Kidins220 (arrows) 






nucleotide exchange factor (RhoGEF) Trio (Neubrand et al., 2010). 
ARMS/Kidins220 has been included in PifA (KAP) family of P-loop nucleotide 
phosphatases (NTPases). P-loop NTPases contain Walker A and Walker B motifs 
(WA and WB, respectively) (Higgins et al., 1988), which are often involved in the 
binding of nucleotides and have been identified in the juxtamembrane regions 
flanking the N- and C- terminus of ARMS/Kidins220. Members of this family are 
predicted to mediate the assembly of protein complexes that are associated with the 
inner surfaces of cell membranes (Aravind et al., 2004).   
The C-terminus of ARMS/Kidins220 includes several protein-protein 
interaction domains, such as a proline-rich region (residues 1080–1092) that binds 
the adaptor protein CrkL (Arevalo et al., 2006), and a sterile alpha motif (SAM; 
residues 1231–1300) (Iglesias et al., 2000; Kong et al., 2001) that might be 
involved in both inter- and intra-molecular interactions. In addition, the kinesin 
light chain (KLC)-interacting motif (KIM) (residues 1387–1426) binds the kinesin-
1 motor complex (Bracale et al., 2007). The last four amino acids of 
ARMS/Kidins220 constitute a PDZ-binding motif that binds the PDZ domain of a-
syntrophin, thereby forming a complex that is associated with the EphA4 receptor 
at the neuromuscular junction (Luo et al., 2005).  
The observation that ARMS/Kidins220 interacts with all three Trk receptors 
and with p75NTR (Arevalo et al., 2004; Chang et al., 2004) prompted a series of 
studies on the role of ARMS/Kidins220 in various aspects of neurotrophin 
physiology, mostly focusing on the molecular mechanisms by which 
ARMS/Kidins220 mediates Trk signaling (Arevalo et al., 2004; 2006). With its 




platform, by recruiting cell-specific adaptors and effectors to activated Trk 
receptors. ARMS/Kidins220 is also involved in functional interactions with several 
other receptors, such as glutamate, ephrin and vascular endothelial growth factor 
receptors (VEGFRs) (Luo et al., 2005; Cesca et al., 2012), thus presenting an 
example of how different trophic pathways can converge and, possibly, be 
integrated at the level of a single adaptor molecule.  
III. ARMS/Kidins220 and neurotrophin signaling 
As previously mentioned, ARMS/Kidins220 interacts with Trk receptors 
(Arevalo et al., 2004), forming a ternary complex with p75NTR (Chang et al., 
2004). The interaction between ARMS/Kidins220 and TrkA is mediated by the 
fourth transmembrane domain of ARMS/Kidins220 and the transmembrane domain 
of TrkA, whereas the interaction with p75NTR involves the last 250 amino acids of 
ARMS/Kidins220 (Kong et al., 2001) and the p75NTR intracellular domain 
(residues 327–342) (Chang et al., 2004). The binding of Trk receptors and p75NTR 
to ARMS/Kidins220 is differentially modulated by neurotrophins. Formation of 
ARMS/Kidins220–TrkA complex is involved in NGF and persists for up to 25 
hours following stimulation with NGF (Kong et al., 2001). However, the assembly 
of the ternary complex between ARMS/Kidins220, TrkA and p75NTR is 
independent of NGF (Chang et al., 2004). Interestingly, increased levels of 
ARMS/Kidins220 reduce the binding of TrkA to p75NTR, suggesting that 
ARMS/Kidins220 regulates the formation of receptor complexes that display 




ARMS/Kidins220 selectively mediates the sustained activation of MAPK signaling, 
without affecting the fast response to neurotrophins or the response to other growth 
factors, such as epidermal growth factor (EGF) (Kong et al., 2001; Arevalo et al., 
2004).  
ARMS/Kidins220 is phosphorylated on tyrosine residues in response to 
NGF and BDNF, the time course of which follows the kinetics of Trk 
autophosphorylation. This suggests that this protein is a Trk receptor substrate 
(Kong et al., 2001). In addition, tyrosine phosphorylation of ARMS/Kidins220 
occurs simultaneously with that of Shc and PLCc, indicating that this protein is 
amongst the first to be activated in response to NGF (Arevalo et al., 2004). The 
adaptor protein CrkL constitutively binds the second poly-proline stretch of 
ARMS/Kidins220 through its SH3 domain (Arevalo et al., 2006). Upon treating 
cells with NGF, ARMS/Kidins220 is phosphorylated at tyrosine 1096, causing a 
conformational change in the CrkL–ARMS/Kidins220 complex. This allows the 
recruitment of downstream modulators of the MAPK pathway, such as C3G and 
Rap1 (Arevalo et al., 2006), and determines its sustained activation, which occurs 
mainly at late endosomes (Hisata et al., 2007). This effect is highly specific, as 
perturbing ARMS/Kidins220 function using RNA interference (RNAi) or 
dominant–negative ARMS/Kidins220 constructs does not affect the transient 
MAPK activation triggered by EGF or the initial steps of MAPK signaling, which 
are Ras- or Akt-dependent (Arevalo et al., 2004). Impairment of BDNF-induced 
MAPK activation has also been demonstrated in ARMS/Kidins220-deficient 
neurons (Cesca et al., 2012). Among the transcription factors activated by the 




signaling when cells are treated with BDNF, mediating neuronal survival 
(Sniderhan et al., 2008). In support of these findings, ARMS/Kidins220–/– 
embryos show widespread cell death in the central nervous system (CNS) and 
peripheral nervous system (PNS) and die at birth (Cesca et al., 2012). Remarkably, 
ARMS/Kidins220 is one of the few proteins that is selectively required for the 
sustained activation of MAPK signaling, whereas most of the other factors act in 
both transient and sustained signaling. Because ARMS/Kidins220 has the role in 
survival pathways such as MAPK signaling, it is recognized as a potential 
oncogene. Accordingly, ARMS/Kidins220 prevents stress-induced apoptosis in 
melanoma cells and contributes to tumor progression (Liao et al., 2007; 2011).   
IV. ARMS/Kidins220 functions are related to pathologies 
Studies performed on ARMS/Kidins220 mutant mice indicate that the 
alteration of ARMS/Kidins220 protein levels impairs neuronal survival and 
development. The complete ablation of ARMS/Kidins220 led to embryonic death, 
which was associated with extensive apoptosis in the CNS and PNS and to 
cardiovascular abnormalities (Cesca et al., 2011). A partial reduction of 
ARMS/Kidins220 levels was sufficient to cause defects in spine turnover and 
synaptic plasticity, with significant repercussions on higher functions such as 
learning and memory, when studied in adult mice (Wu et al., 2009, 2010; Arévalo 
et al., 2010; Duffy et al., 2011). Taken together, the results of these studies strongly 
support the idea that alterations of the ARMS/Kidins220 gene and/or the 
ARMS/Kidins220 protein is associated with human (neuro) pathologies. Although 




several studies have investigated the genetic and molecular pathways linking 
ARMS/Kidins220 to the onset of various diseases. For example, ARMS/Kidins220 
is overexpressed in human samples of melanoma (Liao et al., 2007; 2011), a tumor 
of neural crest origin, and of neuroblastoma (Rogersand Schor, 2013a; Jung et al., 
2014), a cancer type affecting the PNS. In both cases, ARMS/Kidins220 behaves as 
an oncogene, affecting the ability of cancer cells to survive, proliferate and 
migrate/metastasize. Additionally, increased ARMS/Kidins220 levels have also 
been observed in human Alzheimer’s disease (AD) samples (López-Menéndez et 
al., 2013). Here, ARMS/Kidins220 accumulated with hyperphosphorylated Tau 
protein, probably contributing to the defective NT signaling observed in this 
pathology. Alterations of ARMS/Kidins220 gene expression have been found in 
several genetic screens in humans. For example, a microarray-based expression 
profiling of dopaminergic neurons isolated from the substantia nigra of Parkinson’s 
disease (PD) patients revealed that ARMS/Kidins220 levels were significantly 
decreased compared to spectrum disorder (ASD) patients, and found increased 
levels of ARMS/Kidins220 mRNA in ASD patients. Interestingly, genes belonging 
to the NT pathways were overall the most represented of the affected genes (Kong 
et al., 2012). Finally, a very recent study was conducted on a small number of 
schizophrenia patients, by means of high-coverage targeted exome capture on a 
small number of NT-related genes from blood leukocytes. Interestingly, two 
ARMS/Kidins220 missense polymorphisms and one novel gene variant were 
identified in five of 48 schizophrenia patients (Kranz et al., 2015). One of these 
polymorphisms has been subsequently associated with reduced prefrontal 




(Malaspina et al., 2016).  
V. Human mesenchymal stem cells 
Human mesenchymal stem cells (hMSCs) are multipotent stromal cells 
that can self-renew and differentiate into ectodermal and mesodermal cell types that 
can transdifferentiate into cells with endodermal characteristics such as epithelial 
cells and neurons (Fig. 4). They are found in the central nervous system, where they 
guide the differentiation of neurons, astrocytes, and oligodendrocytes from neural 
stem cells (NSCs) (Uccelli et al., 2008). hMSCs contribute to the regeneration of 
mesenchymal tissues such as bone, cartilage, muscle, ligaments, tendons, and 
adipose tissue; provide the stroma for tissue engineering; and have been applied as 
cell therapy for lung injury, kidney disease, diabetes, graft-versus-host disease 
including neurodevelopmental and neurodegenerative diseases, Parkinson’s disease, 
and Alzheimer’s disease (Kennea et al., 2002). 
hMSCs are traditionally derived from bone marrow, which contains a large 
number of red blood cells (RBCs) (Jiang et al., 2002). hMSCs are larger than RBCs. 
Thus, a size-based separation tool is essential to isolate or concentrate hMSCs from 
bone marrow. In addition, the cells can be isolated from cord blood, placenta and 
amniotic fluid (Lee et al., 2004; Yen et al., 2005; Tsai et al., 2006).  
A great deal of research on adult stem cells has focused on their capacity to 
divide or self-renew and their differentiation potential. Adult stem cells are present 
in the brain, bone marrow, peripheral blood, blood vessels, skeletal muscle, skin, 
teeth, heart, liver, ovaries, and epithelium. They are easily derived from peripheral 




Figure 4. The multipotentiality of MSCs. This figure shows the ability of 
mesenchymal stem cells (MSCs) in bone-marrow cavity to self-renew (curved 
arrow) and to differentiate (straight, solid arrows) towards the mesodermal lineage. 
The reported ability to transdifferentiate into cells of other lineages (ectoderm and 
endoderm) is shown by dashed arrows, as transdifferentiation is controversial in 






hMSCs express many surface markers, including cluster of differentiation 
(CD) 29, CD44, CD49-af, CD51, CD73, CD90, CD105, CD106, CD166, and Stro1, 
but lose hematopoietic lineage markers, such as CD11b, CD14, and CD45 (Phinney 
and Prockop, 2007; Lv et al., 2014). hMSCs are known to improve tissue damage 
in response to injury and disease, and their therapeutic effects have been verified in 
animal models of lung injury, kidney disease, diabetes, myocardial infarction, and 
neurologic disorders. Indeed, soluble factors including hepatocyte growth factor 
(HGF), transforming growth factor-β (TGF β), vascular endothelial growth factor 
(VEGF), TNF-stimulated gene 6 (TSG-6), prostaglandin E2 (PGE2), and galectins 
1 and 9, emitted by hMSCs alter the tissue environment and may play a prominent 
role in tissue repair (Prockop, 2007; Madrigal et al., 2014).  
VI. Microfluidics  
In the early 1980s, microfluidic technology developed as a functional 
extension of microelectromechanical systems technology and led to the creation of  
“micro total analysis systems” (μ-TAS) or “lab-on-a-chip” (LOC). These 
miniaturized systems can be used to realize entire procedures performed in 
traditional laboratories with the advantages of decreasing sample/reagent 
consumption, reaction/analysis time, and the risk of contamination, increasing 
sensitivity and reliability, and the ability to run multiple processes sequentially 
(Primiceri et al., 2013; Titmarsh et al., 2014) (Fig. 5). 
Therefore, researchers have been attracted to this technology and have 




Figure 5. Microfluidic technologies add insight to cell therapy processes. This flow 
diagram shows a generic cell therapy implementation process. Bullet points in each 
step highlight areas where microfluidic technologies can add insight. The inset 
shows how integrated microfluidic platforms provide both control of culture 






ranging from the nano- to micrometer scales (Wu et al., 2011). Microfluidic 
systems can be fabricated using a variety of microfabrication processes from 
materials such as polymers, glass, silicon, and metals, depending on the specific 
requirements and specifications. In particular, polydimethylsiloxane (PDMS)-based 
microfluidic devices have several useful characteristics, such as elasticity, durability, 
biocompatibility, optical transparency, gas permeability, no toxicity, and low 
electrical conductivity. PDMS devices are replicated from a mold usually made via 
a soft-lithography technique because of advantages such as low cost, ease of 
fabrication, and rapid processing (MacDonald et al., 2002). A variety of 
microfluidic devices have been fabricated based on this microfabrication process, 
including micropumps, microvalves, and micromixers. Furthermore, these PDMS-
based microfluidic devices can be integrated to perform a specific assay for 
applications such as molecular diagnosis, protein analysis, and cell studies (Wu et 
al., 2011). 
From mid-2000, microfluidic systems developed to offer cells an in vivo-
mimicking microenvironment that is challenging to realize in traditional large-scale 
two-dimensional (2D) systems. Moreover, the capability to perform perfusion 
allowed the infusion of assay reagents while high optical transparency enabled real-
time imaging and analysis of cellular responses. These characteristics significantly 
improved the culture and analysis of stem cells, which are important in the field of 
medicine. Consequently, numerous precision microfluidic platforms have been 
developed for the study of different types of stem cell, including embryonic stem 
cells (ESCs), MSCs, hematopoietic stem cells (HSCs), and NSCs that offer many 




signaling analysis. Specially, monitoring the real-time responses of stem cells yields 
a literal, straightforward result because stem cells tend to undergo morphologic 
changes easily after long experimental processes (Wu et al., 2011; Titmarsh et al., 
2014) (Fig. 5). 
VII. The application of microfluidics in stem cells therapy  
Microfluidics represent an alternative tool for stem cell therapy in clinical 
applications that require rapid isolation and precise counting of these cells and 
accurate control of multiple parameters affecting metabolic rates, viability, and cell 
characterization. Therefore, microfluidic systems may become a powerful platform 
for both fundamental stem cell research and commercial applications in the near 
future.  
Cell sorting or separation—isolating cells of interest from a large number 
of samples, or distinguishing cells that belong to different subgroups—is essential 
for many biomedical and chemical analyses, and is a basic step in many diagnostic 
and therapeutic metho`ds. Traditionally, fluorescence-activated cell sorting (FACS) 
and magnetic-activated cell sorting (MACS) are two of the conventional single cell-
level sorting strategies (Fu et al., 1999; Nilsson et al., 2009). In FACS separation, 
specific antibodies labeled with fluorescent molecules are attached to individual cell 
samples to identify a subset of cells with specific properties. During sorting, the 
cells flow in a stream at a relatively high speed, and a detector sensitive to the 
fluorescent signal is situated along the flow stream. The detector observes either 
light scattering or the presence or absence of the fluorescent signal when each cell 




can be applied to implement separation. For MACS separation, antibody-
conjugated magnetic beads are bound to specific proteins in cells of interest. A 
magnetic field gradient is then applied beside the main stream of the flow of sample 
cells. Subjected to magnetic force, the cells that have bound to the beads are 
isolated from the main stream of the sample. 
Both FACS and MACS rely on antibodies as additional tags or labels to 
identify specific cells. The labeling steps necessary for this can complicate the 
separation processes, and the attachment of antibodies increases the cost of 
separation. Indeed, the attachment of antibodies may have an effect on the 
functionality of the cells. Therefore, it is preferable to use the intrinsic properties of 
cells as biomedical and biophysical markers for separation or sorting. These 
properties include size, shape, electrical impedance, density, deformability, and 
hydrodynamic properties. Studies on these intrinsic properties of cells help 
researchers to achieve a better understanding of cell characteristics and functions. 
The identification and isolation of particular cells from clinical samples may be a 
powerful method of the diagnosis and therapeutic treatment of many diseases. 
Several LOC microfluidic technologies involving label-free cell sorting 
are emerging especially based on cell size and deformability. In size-based sorting, 
active sorting methods apply external optical/magnetic/electrical force fields across 
the cell flow stream, whereas passive sorting methods rely on the structure of the 
microfluidic device or hydrodynamic forces generated in the flow, such as drag 
force and inertial lift force (Di Carlo et al., 2007; Petrsoon et al., 2007; Yamada et 




mechanical pressing, and hydrodynamic stretching are also used for deformability 
based sorting (MacDonald et al., 2003; Geislinger et al., 2014).  
VIII. Microfluidics for size based cell separation 
Size is one of the basic physical properties of a cell. Many microscale 
cell-separation techniques take advantage of these intrinsic properties for high-
performance separation. These techniques can be broadly classified as active and 
passive separation techniques. Generally, active techniques rely on an external force 
field for functionality, whereas passive techniques rely entirely on the channel 
geometry and inherent hydrodynamic forces for functionality. 
Many intrinsic properties of cells, such electrical conductivity, optical 
polarizability, magnetic properties, and mass are relative to cell size. For example, 
electrical impedance or conductivity varies with cell diameter. When subjected to 
an external field that transduces a size-dependent, force-bearing response in the cell, 
the difference in these properties between cell types can be recognized by the 
difference in the magnitude of such forces. Utilizing this phenomenon, several 
types of cell separation have been developed (MacDonald et al., 2003; Pamme et al., 
2004; Petrsson et al., 2007; Vahey & Voldman, 2008) (Fig. 6).  
As cell mixture enters one inlet, the side flow from the other inlet aligns 
the cell sample to one of the channel side walls. When the cells reach the 
fractionation chamber, they come under the influence of the external force field. 
The external force field induces the vertical migration of cells in relation to their 
size. The cells are thus separated when exiting the chamber. By designing a 




Figure 6. Continuous separation in microfluidic systems. Sample or multiple cells 
injected into inlet and flow into each separation chamber with various sorting 
principles; (a) Split flow thin (SPLITT) fractionation (b) optical fractionation (c) 





intrinsic properties are guided to different outlets, thus achieving separation. 
The integration of external force fields, such as split-flow thin-cell (SPLITT) 
fractionation, an optical field, a magnetic field, an electric field or inertial, and Dean 
flow fields, increases the complexity of the device and its production cost (Giddings 
et al., 1985; MacDonald et al., 2003; Pamme et al., 2004; Vahey & Voldman, 2008; 
Petrsson et al., 2007). Also, the biologic structure of the cells may be damaged 
through energy absorption, thus affecting the downstream analysis of the cell 
samples. These disadvantages are motivating researchers to find more reliable 
technologies for cell separation. 
SPLITT fractionation, originally developed by Giddings et al. (1985), is 
based on the difference in velocity between the sample suspension and a carrier 
stream. As shown in Fig. 6a, a particle suspension and a carrier stream are moved 
into a separation chamber at different velocities. Flow splitters at the entrance and 
exit of the chamber smooth the flow and define inner and outer splitting planes. A 
force field, such as gravity, an electric field, or a magnetic field, is applied 
perpendicularly to the direction of flow, deflecting some of the particles into the 
carrier stream (Huh et al., 2007; Lai et al., 2009). Continuous separation using 
magnetophoresis was first reported by Pamme and colleagues in 2004. In this 
method, the suspended particles or cells are separated according to size because the 
larger particles are most affected and subsequently end up in an outlet closer to the 
magnet. This magnetic force is used to modify not only magnetic particle- or 
magnetically labeled cells, but also non-magnetic objects. It is utilized to separate 
white blood cells (WBCs) from red blood cells (RBCs), but it struggles to sort 




One passive sorting method, optical sorting, can be achieved by means of 
an optical interference pattern, a so-called optical lattice (MacDonald et al., 2003) 
(Fig. 6b). A three-dimensional optical field can be generated such that the optical 
force is directed perpendicular to the direction of flow. The optical force on a 
particle or cell depends on optical polarizability. Sorting can be achieved based on 
differences in particle size or refractive index. 
In inertial microfluidics, the particle experiences lifting in a shear-flow 
field environment due to the shear-induced lift-force and wall-induced lift effect 
(Fig. 6d). It results in particle migration across the stream of laminar flow (Bhagat 
et al., 2008), and curved channels produce a secondary flow that arises from a 
mismatch in velocity between central and near-wall regions of a channel. Central 
fluid elements have a larger inertia than fluid elements at the walls, and tend to flow 
outward around a curve, creating a pressure gradient along the curve. The design 
consists of two inlets and two outlets, and the sample is introduced through the 
inner inlet. Neutrally buoyant particles experience lift forces and Dean drag force 
within the microchannel. 
Microchannel cross-sections illustrating the principle of inertial migration 
for particles with ap, which results in differential particle migration (/Dh ~ 0.1). The 
randomly dispersed particles align in the four equilibrium positions within the 
microchannel where the FLs balance each other. Additional forces due to Dean 
vortices reduce the four equilibrium positions to just one near the inner 
microchannel wall. 
Although inertial lift force can affect separation efficiency in 




also be employed for size-based cell separation. The first design to utilize inertial 
lift force for particle sorting was introduced by Di Carlo et al. (2007). Various 
designs based on inertial force-induced separation were subsequently developed by 
many groups (Bhagat et al., 2008; Kuntaegowdanahalli et al., 2009). The significant 
advantage of this method is that separation relies entirely on intrinsic hydrodynamic 
forces. Consequently, the design of the system is simple. Also, because of the large 
channel dimensions (relative to sample-cell sizes), this method can achieve high 
volume throughput and eliminate clogging. However, this method has a limitation 
in terms of the efficiency of tiny cells removed because of their uniform distribution. 
Moreover, the size difference between the cell groups to be separated should be 
considerably large, so that one group can be focused on while no significant inertial 
effect is active on the other groups. 
IX. Hydrodynamic filtration 
Differing from methods that require an external field to induce cell 
separation, HDF is another passive separation method featuring multiple capillary 
branches perpendicular to the main flow thereby aligning all particles along the side 
walls of the main channel (Yamada et al., 2004). In this method, particles are 
introduced into the main channel, and side branches drain liquid from the main 
channel continuously, the smaller particles are closer to the side wall than larger 
particles because of the difference in size, resulting in them being filtered out earlier 
than larger-sized particles. The separation mechanism is based purely on the relative 
flow profile, and not on microchannel geometry. When the relative flow rate in the 




fluid. A medium flow rate is applied to the side channels (Fig. 7b), allowing small 
particles to be separated with the medium, but not large particles, which have a 
hydrodynamic center line outside the dashed flow line that diverts into the side 
branch. Relatively high flow rates in the side channels (Fig. 7c) result in no particle 
separation. The dashed lines in Figs. 7a-c show the virtual boundaries of the layers 
of fluid in the main channel that will be diverted into the side branches. Before the 
separation branches, there are multiple branches responsible for aligning and 
concentrating the particles along the side walls by medium removal. The technique 
has also been demonstrated in the separation of WBCs from RBCs. An alternate 
design, providing improved particle alignment prior to hydrodynamic separation, 
was also developed, in which the carrier medium fractions removed during the 
alignment process were recombined with the main flow (Yamada and Seki et al., 
2006). By adding extra inlets perpendicular to the flow, carrier–medium exchange 
is performed in several steps, providing an aspiration and washing procedure for 
continuous-flow cell processing (Yamada and Seki, 2007). Recently, Seki and his 
colleagues combined magnetophoresis to the concept of HDF-based microfluidics, 
and sorted cells based on size and surface markers (Mizuno et al., 2013). As the 
separation mechanism is based purely on the low profile not microchannel 
geometry, channels significantly larger than the cell diameter can be employed, 




Figure 7. The hydrodynamic filtration principle. Fluids and particles entered into 
main channel are removed gradually from the side branches perpendicular to the 
main flow. This action will eventually line up particles along the main channel 
walls. By controlling the flow rate of the side branch flow it is possible to remove 
particle fractions of a particular size while larger particle moves on to be separated 






Ankyrin repeat-rich membrane spanning (ARMS/ 
Kidins220) scaffold protein regulates neuroblastoma 











Parts of the data shown in this thesis have been published in 





І. Abstract  
Ankyrin rich membrane spanning protein (ARMS/Kidins220) is known as 
an adaptor protein which highly is expressed in nervous system and selectively 
binds to neurotrophin-neurotrophin receptor complex to transfer the signal to 
downstream in nervous system.  
Recent studies have reported that this protein make sustained signal of the 
mitogen-activated protein kinase (MAPK) via CrkL-C3G complex and Rap1 and 
are shown high expression in melanoma. These suggested the ARMS might be a 
potential oncogene and involved in controlling cell cycle.  
In our data, the knockdown of ARMS/Kidins220 inhibits neuroblastoma 
cell proliferation and resulted in inducing slowdown of cell cycle in G1 phase, 
which resulted in resulted in significant reduction of cyclin D1 and CDK4. In 
addition, these decrease of protein levels cause subsequent reduction of pRb 
hyperphosphorylation. Moreover, we observed upregulation of p21, a CDK4 
inhibitor, according to downregulation of ARMS. Taken together, this data suggest 
that p21 inhibit the kinase activity of Cyclin D1/CDK4 and prevent the 
hyperphosphorylation of pRb result in down regulation of cell cycle progression. 
Therefore, our results represent that ARMS/Kidins220 might have a new role as a 
signaling mediator to regulate neuroblastoma proliferation and could be worked as 




II. Introduction  
Ankyrin repeat-rich membrane spanning (ARMS, as known as Kidins220) 
protein has been identified a transmembrane protein and is highly expressed in 
nervous system and colocalized with TrkA-C and p75, as the receptors of on the 
cell surface of sympathetic neurons in the developing nervous system (Igresias et al., 
2000; Kong et al., 2001). It has important roles in neuronal differentiation, survival 
and development. The proteins have multifunctional scaffold protein and its various 
domains for protein-protein interactions (Iglesias et al., 2000; Kong et al., 2001). 
Thus, several research groups have studied the structure and interactions with 
complexes of receptors and effects in various mechanisms (Chao, 2003; Neubrand 
et al., 2012) (Fig. 1).  
Specifically, ARMS/Kidins220 critically acts as a major signaling factor 
involved in prolonged MAP kinase signaling by neurotrophins (Arevalo et al., 2004; 
2006) and might regulate the levels of pMAPK and I nfluence on neuronal cell 
death mediated by excitotoxicity in cerebral ischemia (Lopez-Menendez et al., 
2009).  
Since MAPK signaling is a major survival pathway and Trk receptors were 
initially identified as oncogenes (Martin-Zanca et al., 1986), ARMS/Kidins220 has 
also been suggested as a potential oncogene. Recent studies have been reported the 
relevance between ARMS/Kidins220 expressions and tumorigenic mechanisms. 
The overexpression of ARMS/Kidins220 promoted melanoma formation by 
preventing stress-induced apoptotic death mediated by MEK/ERK signaling 




migration and invasion in metastatic melanoma via activation of MEK/ERK 
signaling pathway (Liao et al., 2011). Moreover, ARMS/Kidins220 expression was 
increased in neuroblastoma cell lines and might stabilize NGF-induced survival 
signaling (Rogers and Schor, 2013a). ARMS/Kidins220 deletion is associated with 
the neural to Schwann like transition in neuroblastoma cell line model (Roger and 
Schor, 2013b). However, the molecular mechanisms of ARMS/Kidisn220 have 
never been investigated in cell proliferation and cell cycle progression.  
In this study, we investigated the role of ARMS/Kidins220 in regulating of 
neuroblastoma cell. We performed to regulate the expression level of ARMS using 
shRNAi in neuroblastoma cell lines and were explored whether ARMS/Kidins220 
regulated cell proliferation via cyclins and CDKs expressions in each cell cycle 





Figure 1. Neurotrophin receptor signaling. Trk receptors mediate differentiation 
and survival signaling through extracellular signal-regulated kinase (ERK), 
phosphatidylinositol 3-kinase (PI3K) and phospholipase Cγ (PLC-γ) pathways. The 
p75 receptor predominantly signals to activate NF-κB and Jun N-terminal kinase 
(JNK), and modulates RhoA activity. These responses are mediated through adaptor 
proteins and might exert effects on apoptosis, survival, neurite elongation and 






III. Materials and methods  
1. Cell culture  
Neuro2a mouse neuroblastoma cells were grown in Dulbecco’s modified 
Eagle’s medium (DMEM, WelGene, Korea) contained with 10% fetal bovine serum 
(FBS; Gibco, CA), 10 U/ml penicillin, and 10 g/ml streptomycin at 37°C with 5% 
CO2. Antibodies against the C-terminus of ARMS/Kidins220 (clone 892, Kong et al. 
2001), cyclin D1, cyclin A, cyclin E, CDK4, ERK, pERK and phospho-pRb 
(Ser780) (Cell Signaling, MA), CDK2, p21, p16, and α-tubulin (Sigma-Aldrich, 
CA) were used.  
2. Generation of ARMS/Kidins220 short hairpin RNA (shRNA) 
retroviral vectors and ARMS/Kidins220-knockdown Neuro2a 
cell lines  
Retroviral vectors producing shRNA against ARMS/Kidins220 were 
constructed by inserting oligonucleotide sequences into pSUPER.puro retro vector 
(OligoEngine, WA) as previously described (Li et al., 2008; Brummelkamp et al., 
2002) (Table 1). Briefly, the pSUPER vector with shARMS sequences was co-
transfected with VM-γP and VSV-G plasmids into 293T cells using lipofectamine 
(Invitrogen, CA) according to the manufacturer’s protocol. After 48 h, the culture 
media containing retroviral supernatants were filtered through a 0.45 μm filter 
(Satorius, Japan). To increase the concentration of virus stock, the filtered media 
was ultra-centrifuged at 250,000 x g for 1.5 h at 4°C using a Beckman SW26 rotor. 




a small amount (1% of original volume) of serum-free DMEM. To performing virus 
titer, we prepared NIH3T3 cells and infected the virus with 10-fold serial dilutions 
into the cells (antibiotic selection). Virus titer are determined by counting the 
number of puromycin (2 µg/ml)-resistant colonies at day 5. To construct the control 
and ARMS/Kidins220-knockdown Neuro2a stable cell lines, Neuro2a cells were 
infected with the retroviral supernatants containing 4 µg/ml polybrene for 5 hr. For 
recovery, cells were cultured in DMEM containing 10% FBS for 48 h and then 
maintained in selection media containing puromycin (2 µg/ml) for next 7 days.  
3. Cell proliferation assay  
For the cellular growth assay, cells were plated in 24-well plates (5 × 103 
cells/well) and counted with trypan blue solution (Gibco, CA) at the indicated time 
points. The cell proliferation was also measured using EZ-CyTox (Daeil Science, 
Korea) according to the manufacturer’s protocol. Cells were plated in 96-well 
plates (3 × 103 cells/well), and 10 µl of assay solution were added to each well. 
Cells were then incubated for 1.5 h at 37°C, and the absorbance was measured by 
the microplate reader (Bio-Rad, CA) at 450 nm.  
4. Fluorescence-activated cell sorting analysis (FACS) 
The cell-cycle distribution was measured by flow cytometry using 
propidium iodide (PI) (Sigma-Aldrich, CA) at indicated times (0, 24, and 48 h).  
The cells were trypsinized, washed twice with cold phosphate buffered saline (PBS), 
and fixed in chilled 70% methanol. Fixed cells were washed twice with PBS, and 




stained with PI (50 µg/ml) for 30 min in the dark (Jadhav et al., 2007). The 
percentages of cells in each cell cycle phase were measured on a FACS Calibur 
system (Becton Dickinson, CA), and analyzed with ModFit LT TM software (Becton 
Dickinson, CA). 
5. Immunoblotting  
To synchronize cells in the Go phase, all cells were cultured in serum-free 
DMEM for 24 h and then stimulated by DMEM containing 10% FBS (0, 4, 8 and 
24 h). At each indicated time, the cells were harvested using cell lysis buffer (10 
mM Tris-HCl (pH 8.0), 150 mM NaCl, 1 mM EDTA, and 1% NP-40 (TNE buffer) 
supplemented with the protease and phosphatase inhibitors. Equal amount of 
proteins (100 µg/lane) were resolved by 6-20% gradient SDS-PAGE, and western 
blotting was performed with antibodies against different proteins.   
6. Statistical analysis  
Data were analyzed using Student's t-test and expressed as mean ± 
standard error of mean (SEM). Probability (P) values < 0.05 were considered 




Table 1. Short hairpin RNA interference (shRNAi) oligonucleotide sequences 
against ARMS/Kidins220.  











IV. Results  
1. Regulation of neuroblastoma cell proliferation by knock-
down of ARMS/Kidins220 
The expression of ARMS/Kidins220 in melanoma cells has been shown to 
confer resistance to UVB-induced apoptosis by activating the ERK signaling 
pathway (Liao et al., 2007). Although it was reported that ARMS might be a 
potential oncogene and can effect on tumor cell survival signaling (Liao et al., 2007; 
2011), the role by which this protein influences tumor cell proliferation has not 
been elucidated yet. Thus, in this study, we investigate the role of 
ARMS/Kidins220 in tumor cell proliferation.  
First, we constructed ARMS/Kidins220-knockdown Neuro2a stable cell 
lines (ARMS-KD) using ARMS-specific shRNA (shARMS)-containing retroviral 
vectors. The control Neuro2a cells were infected with a virus containing vector 
alone. Then, by immunoblotting with ARMS antibody (clone 892), we confirmed 
that ARMS/Kidins220 expression was reduced to 35.9 ± 2% in ARMS-KD cells 
compared with the control cells (Fig. 2a). Next, we performed a cell proliferation 
assay using trypan blue staining to investigate whether ARMS/Kidins220 could 
regulate proliferation. As shown in Fig. 2b, there was no statistical difference in cell 
growth in cell lines on the first day. However, from the second day, the number of 
cells in the ARMS-KD group was different from that of the control group. On the 
fourth day, ARMS-KD cells were numbered 54.9% fewer than the control cells 
(The control, 24 x 103 ± 0.24; ARMS- KD, 13.8 x 103 ± 0.11). 




Figure 2. Knock-down of ARMS/Kidins220 decreases Neuro2a cell proliferation. 
(a) Western blot analysis of Neuro2a cell lysates after shControl and shARMS 
retroviral infection. To verify the suppression of ARMS/Kidins220, Western 
blotting was performed with ARMS (892) antibody and alpha-tubulin antibody. (b) 
Cell counting assay for cell proliferation. Cell proliferation was determined by 
counting the cell number with trypan blue solution at indicated times. (c) Cell 
proliferation test using Ez-CyTox solution. The values are represented as the mean 
± SEM of three independent experiments, and statistical significance is evaluated 





were calculated as approximately 1.88 days and 4.26 days, respectively. To confirm 
this result, we also examined cell proliferation using an EZ-CyTox assay. Consisted 
with the result of the cell counting assay, ARMS-KD cells showed a decreased 
proliferation rate compared to the control cells from the second day, with maximal 
apparent differences on the fourth day (The control, 2.01 ± 0.08 vs ARMS-KD, 
1.03 ± 0.07) (Fig. 2c). Taken together, these data indicate that the expression level 
of ARMS/Kidins220 affects the proliferation of Neuro2a cells.  
2. G1 phase arrest in cell cycle by downregulation of ARMS/ 
Kidins220 
In order to investigate whether ARMS/Kidins220 has a role in cell cycle 
progression, we analyzed cell-cycle phase progression using fluorescence activated 
cell sorting (FACS) in the control and ARMS-KD cells (Fig. 3). First, both cell 
lines were synchronized in the Go phase by serum starvation for 24 h. As expected, 
both cell lines were showed similar proportions in each cell cycle phase at 0 hr. 
However, after the addition of serum, the percentages of the control cell group 
remaining the Go/G1 phase significantly decreased from 54.2 ± 0.9% to 16.9 ± 
2.2%, which indicated the transition from Go/G1 to S phase in cell cycle. On the 
other hand, the proportions of ARMS-KD cells in the Go/G1 phase slightly 
decreased from 50.0 ± 2.1% to 41.7 ± 0.4% (Fig. 3b). At the same time, the 
proportion of the control cells in G2/M phase dramatically increased from 13.9 ± 




Figure 3. Inhibition of G1–S phase progression by knock-down of 
ARMS/Kidins220. (a) FACS analysis shows the distribution of cells in each G1, S, 
and G2/M phase is indicated. (b) The bar graphs indicated the percentage of the 




16.8 ± 2.4% to 27.7 ± 2.9% (Fig. 3b). These results suggest that downregulation of 





3. Reductions of cyclin D1 and CDK4 involved in 
downregulation of ARMS/Kidins220 
Cell growth is regulated by cell cycle regulatory protein, such as such as 
cyclins and CDKs and D-type cyclins (cyclin D1) are especially important for cell-
cycle progression through G1 phase (Sherr, 1995). Decreased cyclin D1 expression 
prevents cells from entering S phase, sustaining them in G1 phase (Baldin et al., 
1993). To verify whether downregulation of ARMS/Kidins220 induced G1 phase 
arrest through regulatory proteins, we performed Western blotting to examine the 
expression of G1 phase regulatory protein, cyclin D1, at different time points of cell 
cycle progression. As expected, downregulation of ARMS/Kidins220 resulted in 
significant decreases in cyclin D1 protein levels at 8, 24 and 48 h, compared with 
the control cells (p < 0.01) (Fig. 4). Although there was some decrease in cyclin D1 
protein levels at 0 h in ARMS-KD cells, this decrease did not reach statistical 
significance. 
To examine the effects of ARMS/Kidins220-knockdown on the other 
cyclins, we also analyzed the expression of cyclin E and cyclin A in both cells. 
Cyclin E is involved in S phase, and cyclin A mainly functions in G2/M phase 
(Furuno et al., 1999). In contrast to cyclin D1, there were no significant differences 
in cyclin E or cyclic A expressions between the control and ARMS-KD cells (Figs. 
4a, 4c, and 4d).  
Interestingly, even at 0 h, without cell-cycle progression, the CDK4 
protein level was significantly decreased in ARMS-KD cells. The expression of 




Figure 4. Decrease of cyclin D1 and CDK4 by knock-down of ARMS/Kidins220. 
(a) Western blot analysis of cyclins and CDKs in the control and ARMS-KD cell 
lines (cyclin D1, cyclin E, cyclin A, CDK4, and CDK2). (b-f) Band intensities from 
three independent experiments were analyzed and normalized to alpha-tubulin. The 
values are mean ± SEM and statistical significance was evaluated by Student’s t-




(Fig. 4f). These results indicate that knockdown of ARMS/Kidins220 is associated 
with the decreased expressions of cyclin D1 and CDK4 in G1 phase but has no 
effect on other cell cycle regulatory proteins. 
4. Inhibition of hyperphosphorylation of pRb via reduction of 
cyclin D1 and CDK4 by downregulation of ARMS/Kidins220 
To examine whether expression levels of cyclin D1 and CDK4 influence 
the downstream pRb pathway, we performed Western blotting with a phospho-pRb 
(Ser780) antibody, which specifically binds to CDK4-phosphorylated pRb. 
Generally, cyclin-dependent kinases (CDKs) are activated by binding of a G1 phase 
cyclin followed by hyper-phosphorylation of Rb (ppRb) and progression into S 
phase (Sherr et al. et 1995; Chen et al., 1989; Jiao et al., 2006). As expected, the 
level of hyper-phosphorylated pRb (ppRb) was decreased in ARMS-KD cells 
compared with the control cells at 24 h. Until 8 h after stimulating, the levels of 
ppRb in both cell lines were no different, however, at 24 h, ppRb in the control cells 
significantly increased than that in ARMS-KD cells. This data indicated that 
reduction of cyclin D1 and CDK4 decreases pRb phosphorylation, which result in 
phase arrest in G1 cell cycle (Figs. 5a-d). Traditionally, the other proteins groups, 
which could regulate cell cycle, are called cyclin dependent kinase inhibitors 
(CKIs), representatively p16, p17, p19, and p21. In this study, we focused on p21 
and p16, which regulate cyclin dependent kinase in G1/S transition. The p21 is 
involved in regulating the function of cyclin D1/CDK4 and cyclin E/CDK2 
complexes (El-Deiry et al., 1993; Harper et al., 1993; Xiong et al., 1993a). 




Figure 5. Reduction of ppRb via alteration of cyclin D1, CDK4, and p21 by knock-
down of ARMS/Kidins220. (a) Western blot analysis of cyclin D1, CDK4, ppRb, 
p21, p16, pERK and ERK in the control and ARMS-KD cells. The loading the 
control is alpha-tubulin. (b-g) The bar graphs show the changes in cyclin D1, 
CDK4, ppRb, p21, p16, pERK and ERK during cell cycle progression in the 








were analyzed and normalized to alpha-tublin. The values are mean ± SEM and 




cyclin D1/CDK4 in G1 phase (Bates et al., 1994; Xiong et al., 1993b). At all-time-
points in our experiment, the levels of p21 protein in ARMS-KD cells was 
significantly higher than that in the control cells (Fig. 5e). In contrast, we did not 
observe any significant differences in p16 between the two cell lines (Fig. 5f). 
These results indicate that knockdown of ARMS/Kidins220 upregulates p21 
protein expression, thus inhibiting cyclin D1/CDK4 function in G1 phase of cell 
cycle. Next, we examined the activation of the p42- and p44-kDa extracellular 
signal regulated kinases (ERKs) in ARMS-KD cells since ARMS/Kidins220 was 
shown to act as a platform for sustained Erk activation in neurons through the 
recruitment of CrkL (Arevalo et al., 2004; 2006) and ARMS/Kidins220-
knockdown downregulates ERK activity in melanoma cells (Liao et al., 2007; 
2011).  
Consistent with previous studies, the level of pERK protein in ARMS-KD 
cells was decreased at early time points compared with the control cells, especially 
at 60 min (p < 0.05) (data not shown). We also the level of pERK protein in 
ARMS-KD cells was significantly decreased at 24 h compared with that in the 
control cells (p < 0.05) (Figs. 5a and g). Taken together, our results suggest that 
downregulation of ARMS/Kidins220 inhibits neuroblastoma cell-cycle progression 




Figure 6. Diagram depicting how ARMS/Kidins220 regulates cell cycle 
progression. Knock-down of ARMS/Kidins220 controls cell proliferation rate and 
reduces the cyclin D1 and CDK4 in G1 phase. Moreover, knock-down of ARMS is 
involved in upregulation of p21, leading to inhibit cell proliferation. Inhibition of 
cyclin D1 and CDK4 could result in hypo-phosphorylation of pRb family proteins 
and subsequent sequestration of E2F transcription factors. The transcriptional 
activation of E2F-responsive genes is essential for DNA synthesis and cell cycle 
progression. Taken together, our results suggest that reduction of ARMS expression 
is able to induce the expression of p21, leading to inhibition of cyclin D1 and 




V. Discussion  
ARMS/Kidins220 is a transmembrane protein with four membrane-
spanning domains and is consisted of 11 ankyrin repeats, a polyproline region, and 
a SAM domain as well as the C-terminal PDZ-binding sites (Kong et al, 2001; 
Arevalo et al., 2006 ; Neubrand et al., 2012).  
ARMS/Kidins220 is highly expressed in the nervous system and has 
important roles in neuronal differentiation, survival and development via its various 
domains for protein-protein interactions (Iglesias et al., 2000; Kong et al., 2001). 
Thus, several research groups have studied the structure and interactions with 
receptor complexes and determined effects in various mechanisms (Chao, 2003; 
Neubrand et al., 2012).  
Recently, ARMS/Kidins220 expression is highly increased in human 
melanoma compared to benign skin lesions, and prevents stress-induced apoptosis 
in melanoma cells by activating ERK pathway (Liao et al., 2007). Moreover, it has 
been reported that ARMS/Kidins220 regulate phosphorylation of MAPK, resulted 
in neuronal cell death by mediate excitotoxicity in cerebral ischemia (Lopez-
Menendez et al., 2009). In addition, the roles of ARMS/Kidins220 in physiological 
functions have been reported in the vascular and nervous systems (Cesca et al., 
2012) but the mechanisms have not been clearly elucidated. Similar to Trk 
receptors as oncogenes, ARMS/Kidins220 might have a critical role involved in 
regulating of tumorigenesis (Martin-Zanca et al., 1986; Liao 2007; 2011). Although 




progression, its role in cell proliferation and cell-cycle progression has never been 
investigated. 
Generally, the oncogenes might have functions to increase cell-proliferation 
by stimulating cell cycle progression. As a tumor suppressor, pRb inhibits cell cycle 
progression at G1/S by blocking the activity of the E2F family of transcription 
factors, which activate the genes required for induction of S phase (Dulic et al., 
1994). Rb function is regulated through cell cycle by phosphorylation (Chen et al., 
1989). Hyperphosphorylation of pRb by cyclin-CDK complexes in G1 phase 
inactivates its growth suppression function; consequently, G1 restriction point is 
bypassed (reviewed in Malumbres and Barbacid, 2009). 
In this study, ARMS/Kidins220-knockdown induced the cell growth rate 
slow down and regulated cell cycle via sustaining in G1 phase. The downregulation 
of ARMS/Kidins220 was associated with the decreased expressions of cyclin D1 
and CDK4 in G1 phase. The expressions of other regulatory proteins such as cyclin 
A, -E, and CDK2 were not changed. Cyclin D1 is often overexpressed and 
associated with tumorigenesis in many cancers and loss of cyclin D is sufficient to 
cause G1 arrest in other cellular contexts (Masamha and Benbrook, 2009). Cyclin 
D1/CDK4 level was significantly decreased in ARMS-KD cells and was tightly 
associated with p21 upregulation in our experiment. In contrast, p16, another of 
CKIs, was unchanged. Indeed, the level of ppRb was also reduced in ARMS-KD 
cells than the controls at 24 hr after the cell-cycle entry.  
 Consistent with previous studies, we also found that pERK level was 
reduced after ARMS/Kidins220 knockdown (Arevalo et al., 2004; Liao et al., 2007; 




with CrkL (Arevalo et al., 2004; 2006), it will be interested to examine which 
adaptor(s) or effector(s) is involved in ARMS/Kidins220-p21 pathway of cell cycle 
regulation. Identifying the specific domain of ARMS/Kidins220 involved in the 
regulation of p21 expression using the serial deletion constructs of 
ARMS/Kidins220 will be useful to further delineate this pathway. Another 
interesting question to address will is be whether ARMS/Kidins220 is also involved 
in other tumor cells and normal cell proliferation by the same mechanism 
demonstrated in our study. Although the role of p21 is still controversial, it is clear 
that p21 inhibits cyclin D1/CDK4, which results in retarded cell proliferation in this 
study.  
In summary, we demonstrated that ARMS/Kidisn220 regulates 
neuroblastoma cell proliferation by regulating cyclin D1/CDK4, resulting in 
upregulation of p21 proteins. Therefore, our results suggest that ARMS/Kidins220 
acts as an important platform for organizing the signaling complex to regulate cell 
cycle progression in response to extracellular stimuli and may serve as an important 






Sorting of human mesenchymal stem cells by applying 
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Human mesenchymal stem cells (hMSCs) have the ability to replicate self-
renewal and to differentiate into multiple cell types that allow them to use tissue 
engineering and cell therapy. Recent studies have reported that the MSCs consist of 
heterogeneous populations with variable morphology, making a limited capacity for 
self-renewal, and less efficiently differentiated (multipotent properties). Thus, to 
getting the purified hMSCs with high potential is important step for increasing the 
efficiency of stem cell therapy.   
Here, we have sought to develop and validate a novel method to collect a 
desired size of hMSCs by microfluidic chip with the hydrodynamic filtration (HDF) 
principle. HDF is a principle which is similar to cross flow filtration which utilizes 
small capillary branches perpendicular to the main flow. When a particle is flowing 
in a microchannel, the center position of the particle cannot be present in a certain 
distance from sidewalls, which is equal to the particle radius.  
Using this multibranched channel, we conducted the separation of hMSCs 
and fractionate the cells into three subpopulations, i.e., small, rapidly self-renewing 
(RS) (< 25 µm), spindle-shaped (SS) (25-40 µm), and large, flattened (FL) (> 40 
µm) cells. The results obtained in this study demonstrate high purity (> 86%) and 
successful recovery (> 80%) of each group of cells. Through verify surface marker 
expressions (CD73, CD90 and CD105) of collected cells in each outlet, the RS and 
SS cells show high levels of CD73, CD90 and CD105 while, FL cells do not show 
any the expression of CD73. In addition, to investigate the sorted population’s 




differentiations and then compared the multilineage potentials of each 
subpopulation. From comparing the expressions of the marker genes in each group, 
we determined that the marker genes expressions involved in differentiations in RS 
and SS populations had significantly increased than in FL group cells. In addition, 
RS and SS groups had higher differentiation potential than the unsorted populations 
because they contained FL cells with lower potential. These results indicate that the 
HDF multi-branch chip successfully sorted hMSCs based on size, and that cell size 
appears to be closely related to multipotency and can serve as an indicator of 







Human bone marrow-derived mesenchymal stem cells (hMSCs) have been 
considered as a cell therapy for regenerating of damage tissues or various diseases 
and applied for tissue engineering. They could divide of self-renew and have 
potentials to differentiate into cell with adipocyte in the ectoderm, osteoclast in the 
mesoderm and trans-differentiation endoderm such as epithelial cells and neurons 
(Pitternger et al., 1999; Colter et al., 2001; Pinney and Prockop, 2007; Sherman et 
al., 2011). Although these hMSCs are eligible for these medical applications, there 
are still potential limitations.  
There have been reported that hMSCs consist of heterogeneous 
subpopulations of stem cells, which have different self-renewal ability and 
multipotent potentials (Smith et al., 2004; Haasters et al., 2009). First, they have 
been classified into small rapidly self-renewing cells (RS), elongated, spindle-
shaped cells (SS), and slowly replicating, large, flattened cells (FC) based on the 
size. Moreover, smallest RS cell populations have been shown to have the highest 
multipotency to differentiate into various cell types, while large FC cells are 
regarded to be very early osteogenic progenitors with subsequently losing stem cell 
characteristics. Thus, sorting these stem cells based on their size and concentrating 
target populations with high multipotency are important to increase the 
effectiveness of cell therapy. There have been many researches for manipulation 
and sorting of cells in biomedical applications such as cell biology, clinical 
diagnostics, and oncology Fu et al., 1999; Nilsson et al., 2009; Gao et al., 2013; 




very important and basic step for studying their biological and physical properties. 
Traditionally, cell sorting and separation is achieved by FACS and MACS. Both 
methods have high quality sorting efficiency and achieve high throughput but 
required inevitable, irreversible, labeling steps with specific antibodies with high 
cost and further experiments restriction and need for high cost complicated device 
with well training operation skills. These factors could be restriction points to 
sorting experiments (MacDonald et al., 2003; Schneider et al., 2010).  
Microfludidics and microfabrications could be shown the alternative 
methods to these traditional sorting systems and recent studies have reported that 
manipulate particles and living cells (Hyun et al., 2013). There are classified into 
two separation principles, active separation and passive separation. The active 
separation is applied for microfluidics with external fields factors, such as 
magnetophoresis, dielectrophoresis, and optical method (MacDonald et al., 2003; 
Schneider et al., 2010). These methods were considered for increasing sorting 
efficiency but results in high costs production and complicated device designs. 
Instead, the passive separation sorting methods used the barriers of channel 
obstruction pattern, hydrodynamic effect or the combinations of both within a 
microfluidic device achieve separation, respectively.  
Specially, hydrodynamic effects understand the flow profile and interaction 
in microfluidic channel to obtain separation based on the inertial force (Di Carlo et 
al., 2007; Aota et al., 2011), pinched flow (Kawamata et al., 2008) and HDF (Stone 
et al., 2004; Yamada et al., 2007; Bruus, 2008; Sugaya et al., 2011). Using HDF 
principle, mid-2000, Seki groups introduced a microfluidic chip with multiple 




sorting efficiency. The particles or cells are injects through main inlets and aligned 
into the wall by side supporting flow. Then there are occurred the selective flow 
fractionation along to side branched channel and determined the flow distributions 
relative to the hydraulic resistances. By these HDF, they performed various cells 
separation experiments, such as liver cells, white blood cells (WBC) from red blood 
cells (RBC), JM cells (human T-lymphocyte cell line), and HeLa cells (human 
epithelial tumor cell line) (Stone et al., 2004; Yamada et al., 2007; Bruus, 2008). 
The basis of flow-based HDF is implemented from conventional crossflow 
filtration which employs numerous capillary branches perpendicular to the main 
flow. HDF is relatively simple and approachable for continuous separation of 
particles or cells without chemical treatments and external fields, compared to 
many recent flow-based separation methods. By the mechanism called particle 
focusing, the branches manage to remove the medium and align particles to the 
sidewalls of the main channel (Yamada et al., 2005; Lenshof and Laurell, 2010).  
In this study, we applied a microfluidic chip with HDF for sorting 
populations from heterogeneous hMSCs populations not targeting a specific size 
cells from unrelated, arbitrary crowds. First of all, unlike previous studies, we 
clarified the analogy of pressure-driven laminar flow in microfluidic networks and 
intended trimodal separations subjected to the possible classification of hMSC with 
three fractions. Multi-branches connected to main channel are effective in removing 
excess fluid gradually, aligning of the cells eventually along the main channel walls.  
The cells were injected through main inlet and moved into the side branches 
by side flow, according to the focusing with a proper ratio between main and side 




parallel to the direction of side inlet for focusing. According to the focusing with a 
proper ratio between main and side flow rates, cells were move into the side branch 
by side flow. To estimate the sorting efficiency of our designed chip, we analyzed 
efficiency, the recovery ratio of different outlets for each fraction and the purity of 
each fraction at different outlets. Our results demonstrated the validity of 
microfluidic chip filtration and showed its possible application to the rapid and 
precise fractionation of hMSCs with high multipotency.  
 Fig. 1 represents size-selective separation enabled by flow focusing effect 
caused by flow fraction between main and branch stream. In other words, with 
proper the control of flow fraction, some particles with hydrodynamic centers in the 
branch stream region are diverted into branch channel and other particles flow 
along the main stream. The width of the gray-colored region in Fig. 1 denotes the 
virtual boundary of the fluid layer is termed as cut-off width (Wc), which is a key 
factor to determine size of particles to be diverted into the branches. Here, we 
assume that particles continuously flow through the channel in full width. In the 
straight main channel after entrance length, L/rh = 0.1Rerh , since L >> L0,  the flow 
is reasonably assumed to be fully developed flow in most of the channel, where L is 
the channel length, rh is the equivalent hydraulic radius, and Re means Reynolds 
number. Hence, the analysis of flow fraction of two streams is essential to HDF 
principle. In this study, the suspending fluid without feed material is supplied from 
the side channel flow to a certain angle, where we carefully chose as 60º. 
The flow fraction of main and side streams is analytically examined from 
derivation of the flow ratio between two streams. Considering the shape of 




at the rectangular cross-section with arbitrary aspect ratio.  
As we assume the medium as a Newtonian fluid and fluid flows as steady 
state laminar flow in a straight channel, the governing equation is given by Stokes 
equation, 2 Pµ∇ = ∇v . For rectangular microchannel with the width W and the 









.                  (1) 
Here, vz is the streamwise axial velocity in z-direction, P is the pressure drop 
applied along the channel length, and µ is the fluid viscosity.  
The analytical solution for v with no-slip boundary condition is given by (Yamada 
et al., 2007)  
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The streamwise average velocity is obtained by integrating Eq. (2) with respect to 
the y-direction,   
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Further, the average velocity in the channel is obtained by integrating Eq. (3) along 
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Further, we subdivide the main channel stream and set the focused stream of −X ≤ x 
≤ 0 (or 0 ≤ x ≤ X, due to symmetry) with X = W/2 − WC, for detailed analysis of 
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In Fig. 2, the virtual boundary is observed in the forefront of the initial branch point 
where main and side streams merge. The width of this virtual boundary can be 
mathematically predicted from a proportion of two streams. Our previous study has 
defined the ratio of flow rates of two streams as the ratio of flow fraction, ξ (Jung et 
al., 2015). By employing the relationship of total flow rate and fractional flow rate, 
m S
i iQ Q Q+ =  and / 2
m
i xQ Q Q+ = , ξ can be expressed as 
( ) ( )2 2X Xm sQ Q Q Q Q Qi iξ ≡ = − + .             (7) 
The equation above is rearranged with Γ1 = tanh(nπW/2H), Γ2 = cosh(nπW/2H), 
and Γ3 = sinh(nπX/H) and rewritten as 
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To achieve trimodal separation from the hMSC populations, our 
microfluidic chip is designed to have three outlets as shown in Fig. 3. The hMSCs 
in certain range enter the corresponding branches where the ratio of flow fraction is 
optimized for the specific size. The sorting can be improved with proper the control 
of the ratio of flow fraction for each branch channel. In steady state flow, we 
observe the parabolic velocity profile, or fully-developed flow at the distance of 
approximately 0.1Rerh from the node of main and side channels. After this distance, 
the streamline becomes parallel to the main channel and laminar flow is then 
observed. Branches are constructed from this point forward and for more accurate 
design we have divided the main channel into the number of branch points, as 
marked in Fig. 1. The branch point, Sb, is significant since the complex input fluid 
begins to diverge into two streams: optimized amount of flow enters the branch 
channel and the rest remains in the main channel. At this point, the ratio in Eq. (8) is 
equivalent to the ratio of flow rates in branch and main streams at specific jth 
branch point Sj.   
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The number of terms required for sufficient accuracy is subject to H/W and WC. 
Here, the equation converges with less than 4 terms (i.e., n = 1, 3, 5).  
 From Eq. (5) with rapidly converging sum, the flow rate at the main 
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Since the corresponding flow rate 1,−
m
j jQ  is represented by subtracting output flows 
at branches from 1st to (j-1)th from the total input flow Q, the pressure drop at the 
corresponding interval is estimated as 
      ( )11, 1, 1jm m bj j j j jP R Q Q−− −∆ = −∑ .             (11) 
The first 48 branch channels and next 7 channels deviated from the main channel 
are connected to outlet 1 and outlet 2, respectively, where the main channel 
connects inlet 1 and outlet 3 with an invariant width. 
All branches are slanted to the angle of 60º which is parallel to the side 
stream. This geometry is determined from our preliminary study which has resulted 
in higher efficiency in slanted channel than perpendicular configurations (Jung et al, 
2015). Branches connected to both outlet 1 and 2 are composed of multiple 
channels for effective separation of particles. The design of multiple branches is 
responsible for aligning against sidewalls and concentrating the particles by fluid 
removal, providing the separation enhancement. Branches are designed to have two 
parts: a narrow section and a wide section. Yamada and Seki suggested that 
specifying the narrow and wide section allows keeping the total length of branch 
channels uniform by adjusting the hydrodynamic resistance properly (Yamada et al., 
2005). The narrow section exists for practical application of pressure drop, and the 
wide section works as a reservoir with a relatively broadly width to prevent the 
reverse flow in the process of particle discharge. Branch channels are designed to 
consist of narrow and wide segments that make the total lengths of the channels 
uniform by adjusting their hydraulic resistances to specific values. Thus, the flow 
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Table 1 suggests the design parameters we have used in this study. In 
hydrodynamic filtration, the virtual boundary width is considered as WC. If the 
hydrodynamic center of particles is located in this width, colored in white in Fig. 1, 
those particles will be diverted into the following branches and vice versa; thus, 
objective particle size primarily determines the cut-off width. The targeted 
parameters in chip design calculation are lengths of narrow section of each branch 
channel and length between the last branch and outlet 3. We set the heights and the 
widths of main as well as branch channels, total lengths of main and branch 
channels, and inter-distances between each branch channel.  
Objective parameters are each length of individual branch channels and the 
length between the last branch and outlet 3. The pressure drops between inlet and 
every outlet point are set to equal on the ground that the main and all branch 
channels are open to the atmosphere, yielding 
            ,1 , , 3i i j i OP P P∆ = = ∆ = = ∆   .           (15) 
Note that the pressure drop is basically described as the product of the flow rate and 




guess of 1bL , and then for that specific pressure drop value, 
b
jL  is repeatedly 
computed by iteration scheme on the condition of ,1 ,i i jP P∆ = ∆  in the multiple 
branches. Sufficient minimum tolerance is acknowledged in the nonlinear 
regression with the least sum of squares method based on generalized reduced 
gradient (GRG) scheme. Similarly, the length between the last branch and outlet 3 
( 55,O 3
mL ) can be determined by iteration scheme on the condition of  ,1iP∆  = ,O 3iP∆ . 
 The configuration of the microfluidic chip is shown in Fig. 2. The chip 
consisted of two inlets from main and side channel and fifty five branch channels 
connected to three outlets reservoirs (Fig. 3). The first forty eight branch channels 
were connected to outlet 1, each of which was composed of narrow and broad 
segments, with properly adjusted flow resistances. The next five branches are 
connected to outlet 2 and others are subjected to outlet 3. The slanted branch 
channels are directed to 60º to the main channel and the length between ,1
m
iL  and b1 
is 2,000 µm long to help the fluid reach steady state. The dimensions of each 




Figure 1. Schematic of the flow fraction of HDF of particles in microchannel with 





Table 1. Design parameters and values of multibranched sorting chip. 
 
 
Channel Dimension  Notation Values (µm) 
Main Height  H 65 
 Width  W 90 
 Length  ,1
m
iL  440 
   1,
m
j jL −  (j = 1-48) 280 
   1,−
m
j jL  (j = 49-55) 280 
   55, 3OmL  1140 
 Cut-off  
1CW  12.5 
   
2CW  20 
Branch Height  H 65 
 Total length  bTjL  (j = 1-48) 30000 
   bTjL  (j = 49-55) 1000 
 Width Narrow section bjW  (j = 1-48) 54 
   bjW  (j = 49-55) 75 
  Wide section bRjW  (j = 1-48) 90 
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Figure 2. The HDF and multi-channel network in the sorting chip. (a) Schematics 
of HDF microfluidic chip for sorting of particles and hMSCs, and (b) multi-channel 





III. Materials and methods   
1. Sorting chip fabrication  
The microfluidic chip were fabricated the microfluidic chip designed with 
all values of channel dimension (shown in Fig. 2 and Table 1). All procedures were 
followed by the standard soft lithography protocols (Yoo et al, 2014). Channel 
design was performed with AutoCAD-2009 (Autodesk Inc.) and the photomask 
was prepared for the fabrication of a master mold on a silicon wafer (boron doped, 
p-100). In order to create the master mold, the photolithography was employed with 
the negative photoresist (PR) SU-8 2050 (Microchem, Newton, MA) which coated 
onto the cleaned wafer by spinning. After UV (wave length = 365 nm) patterning 
by the mask on the PR for 10 sec with the mask aligner (MA-6 mask aligner, 128.6 
mJ/cm2), the post exposure bake was carefully performed and then the unexposed 
PR was removed by dissolving with the SU-8 developer (Microchem, Newton, 
MA). For PDMS replica with the designed patterns, Sylgard 184 (Dow Corning, 
MI) silicon elastomer prepolymer was mixed in 1:10 ratio with curing agent and 
pouring on onto the molding master. After sufficient degassing, the PDMS layers 
with mold were baked at 80oC for 1 h. The cured PDMS replicas were peeled off 
and the holes were punched for two inlets and three outlets by 1.6 inch puncher. 
Prepared PDMS replicas were bonded to the glass substrate followed by O2 plasma 
treatment (70 W, 40 sec, CUTE-1MP, FemtoScience, Korea). For enhancing the 
bonding strength, the assembled device was finally performed post-backing in an 





Figure 3. The multibranched chip for sorting of particles and hMSCs. (a) 
Schematics of the microfluidic chip fabrication procedures and (b) the CAD and 
master mold of the microfluidic chip used in this study. (c) The completed sorting 
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2. Sorting chip operation   
 The sample suspension was introduced into the main channel through the 
main inlet using a syringe pump (Pump 11 Elite-Nanomite, Harvard Apparatus, 
MA), and the medium fluid was injected into the inlet 2 by another pump (KDS-
200, KD Scientific, MA) (Fig. 3). The microfluidic chip was positioned under an 
inverted microscope (Eclipse Ti-E and Eclipse TE2000, NiKon, Japan) with a 10 x 
objective lens to allow monitoring and imaging. Most images were taken by a 
digital 5M pixel sCMOS camera (Zyla, ANDOR, UK) and particle streak images 
were captured at exposure time of 150 ms with NIS-Elements software. The cell 
deformation was observed by an ultra high-speed CMOS camera (FastCam SA1.1, 
Photron, Japan) with 10,000 frames/sec and a 15,000-1/sec exposure time. All 
sorting data were obtained from at least 3 times and were analyzed by the ImageJ 
(NIH, MD).  
3. Sample preparations for side flow performance and particle 
sorting  
Prior to all of the experiments, all solutions should be are filtered through 
0.2 µm syringe filters (Sartorius, Japan) for preventing the clogging in the channel. 
For flow distribution experiment, the main fluid, only distilled water, was 
introduced through the main inlet and trypan blue (0.4%) solution (Gibco, CA) was 
injected from side inlet through Teflon tubing consisted with 1.5 mm (OD) and 0.8 




various flow rate (Qt) and the ratio of side flow rate (Qs) to main flow rate (Qm) 
(Table 2). 
To examine the fabricated micro devices work, the fluorescent polystyrene 
latex particles (Thermo Fisher Scientific Inc. MA) with diameter 15 and 39 μm 
were added into pre-filtered 0.2% triton-X 100 solutions (300 ppm) and gently 
mixed using a stirrer for 30 min. Simultaneously, prior to experiment, the 
microfluidic chips were washed for 30 min with dust free 0.2% (w/v) Triton X-100 
and filed the solutions to maintain hydrophilic status. The particle mixture was 
sonicated for 30 sec and then confirmed that the particles did not aggregate in the 
suspension under the microscope.  
The prepared particle solutions was continuously injected into the 
microchannel using the main syringe pump, while the solution without particles, as 
a sheath flow, were introduced from the inlet by side syringe pump. Total flow rate 
(Qt) was constant for all experiments at 30 μL/min and the ratio of side flow rate 
(Qs) to main flow rate (Qm) was fixed at 6. After separation experiments, collected 
particles in each outlet were taken images under the microscopy and the efficiency 
of separation was analyzed by the image J (NIH, MD).  
4. hMSCs culture and preparations for cell sorting 
hMSCs were purchased from Cambrex (Walkersville, MD) and were 
culture in low glucose dulbecco’s modified eagle’s medium (DMEM, Welgene, 
Korea) supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin 
(Gibco, CA) at 37oC with 5% CO2 . Cells were plated at a density of 4 x 104 cells 




Table 2. The changes of virtual Wc based on total flow and the flow rate ratio.   
* flow rate (μL/min); wall shear rate (1/sec); ΔP (bar/cm)  









0.3 0.04 0.17 
1:6 
39.33 0.085 0.06 0.817 x102 0.0004 
0.5 0.06 0.44 39.33 0.142 0.11 0.136 x103 0.0007 
1 0.14 0.86 16.85 0.285 0.22 0.272 x103 0.0014 
3 0.43 2.57 14.98 0.855 0.65 0.817 x103 0.004 
5 0.71 4.29 13.11 1.42 1.08 0.136 x104 0.007 
30 4.29 25.71 9.72 8.55 6.45 0.817 x104 0.043 
50 7.14 42.86 9.26 14.2 10.8 0.136 x105 0.072 
100 14.3 85.71 8.70 28.5 21.5 0.272 x105 0.144 
200 28.6 171.4 3.75 57.0 43.0 0.545 x105 0.289 
30 
10 20 1:2 29.62     
7.5 22.5 1:3 24.41     
4.29 25.71 1:6 9.72 8.55 6.45 0.817 x104 0.043 
2.73 27.27 1:10 9.36     




confirm size-distribution of heterogeneous hMSCs, we captured both images of the 
cells at cultured and suspended states and analyzed the area and length of cells by 
the ImageJ (NIH, MD). It is reasonably assumed that the cell diameter can be 
calculated by a 2-dimesional ellipsoidal particle with major axis Ll (the longest 
length) and minor axis Ls (the shortest length). 
For sorting experiments, the hMSCs were suspended at a concentration of 
1.0 × 105 cells/100 μL in DMEM media. Briefly, hMSCs were added to the main 
inlet at 4.3 μL/min and the media were introduced into side inlet at 25.7 μL/min, 
respectively. The hMSCs populations were collected from each outlet, and their 
sizes in taken pictures were measured and analyzed by the software ImageJ (NIH, 
MD). The values are represented as the mean ± SEM of three independent 
experiments and the efficiency of separation was represented as the recovery and 
purity ratio, as previously mentioned.  
5. Viability and growth of hMSCs subpopulations   
To confirm the cell viability and cell growth, sorting populations from each 
outlet were assessed via the trypan blue exclusion staining. Cell viability is 
calculated as the number of viable cells divided by the total number of cells in the 
grids on the hemocytometer. To investigate the differences of growth rate between 
sorting populations, 150 cells per each population were seed on the 96 wells and 
cultured for 7 days. On the everyday, the cell numbers were counted with trypan 






6. The surface marker expressions of hMSCs subpopulations-
immunocytochemistry 
After sorting of hMSCs based on the size, we analyzed the surface marker 
expressions of each subpopulation using immunocytochemistry as previously 
described (Haasters et al., 2009). The hMSCs collected from each outlet were 
seeded at a density of 1.0 x 104 cells and were cultured for 48 h. Then, cells were 
fixed with 4% paraformaldehyde (PFA), permeabilized in 0.2% Triton X-100 and 
blocked with 5% normal goat serum (NGS) in phosphate-buffered saline (PBS) for 
1 h. Each sorting populations were incubated overnight at 4oC with the following 
primary antibodies: mouse monoclonal anti-CD73, 1:500 (Invitrogen, CA) and 
rabbit polyclonal anti-CD90, 1:500 (Abcam, Cambridge, UK) or rabbit polyclonal 
anti-CD105, 1:250 (Abcam, Cambridge, UK). After washing with PBS, cells were 
incubated with the following secondary antibodies: Alexa Fluor 546 anti-mouse 
IgG (Invitrogen, Paisley, UK) and Alexa Fluor 488 anti-rabbit IgG (Invitrogen, 
Paisley, UK). Cells were counterstained with 4,6-diamidino-2-phenylindole (DAPI; 
Santa Cruz Biotechnology, CA) for nuclear staining. The z-stack images of 
immunopositive cells were captured using a laser scanning confocal microscope 
(LSM700, Carl Zeiss, Germany). 
7. Adipogenic, osteogenic, and Schwann cell differentiation 
from sorted hMCSs 
First, each size-sorted subpopulation and unsorted hMSCs were seeded at 




adipogenic induction, the confluent cells were incubated in DMEM with 10% FBS, 
0.1 μM dexamethasone, 10 μg/mL insulin, 0.5 mM 3-methyl-1-isobutylxanthine, 
and 50 μg/mL indomethacin for 7 days (Lee et al., 2014a). For osteogenic induction, 
the cells were cultured in medium containing 0.2 μM dexamethasone, 10 mM 
glycerophosphate, and 50 μg/mL ascorbic acid for 7 days (Byun et al., 2012). All 
experiments were processed with the unsorted group under differentiation 
conditions and the unsorted groups under non-differentiation conditions 
simultaneously as the control s. The differentiation media were replaced every 2 
days, and all reagents for cell differentiation were obtained from Sigma-Aldrich 
Corp. (Sigma-Aldrich, CA). Schwann cell (SC) differentiation of hMSCs was 
induced as reported previously (Park et al., 2012). First, the sorted subpopulations 
and the control cell groups were plated at a density of 3 × 104 cells/well in 24-well 
plates, and cultured with growth media containing 1 mM β-mercaptoethanol for 24 
hr. Next, the cells were cultured in differentiation medium including 0.28 μg/mL 
all-trans-retinoic acid for 3 days. Then, the cells were incubated with medium 
containing 10 μM forskolin, 10 ng/mL recombinant human basic fibroblast growth 
factor (bFGF), 5 ng/mL recombinant human platelet-derived growth factor-AA 
(PDGF-AA), and 200 ng/mL human heregulin-β1 (HRG- β1) for 8 days (Dezawa 
et al., 2001; Park et al., 2012). The differentiation media were replaced every 2-3 
days, and all reagents for cell differentiation were purchased from Sigma-Aldrich. 
 
8. Oil-Red O and alkaline phosphate staining  




10 min at room temperature and then incubated with the appropriated staining 
solutions. Adipogenic differentiated groups were reactive with 0.3% Oil Red O for 
30 min in dark (Lee et al., 2014a). Lipid droplets can be visualized with Oil Red O, 
a lysochrome diazo dye that stains neutral triglycerides, lipids, and lipoproteins. 
After removing the staining solution, the cells were washed 3 times with H2O 
followed by observation. For alkaline phosphatase staining, the osteogenic 
induction cells were stained with 0.1 mg/ml naphthol AS-MX phosphate, 0.5% 
N,N-dimethylformamide, 2 mM MgCl2, 0.6 mg/ml fast blue BB salt, and 0.1 M 
Tris-HCl (pH 8.5) for 30 min at room temperature (Byun et al., 2012). Alkaline 
phosphatase (ALP) is a membrane-bound glycoproteins and is bound to the 
membrane of osteoblast and functions to enhance osteogenesis by degrading 
pyrophosphate. In ALP staining, formazan dye with a bluish-purple color is 
generated in the presence of alkaline phosphatase through a reaction mediated by 
components in the substrate solution (Zhu et al., 2010). After staining, the staining 
solution was removed, and the cells were washed three times with H2O. The stained 
cell images were taken by CCD camera (AxioCam-HRC, Carl Zeiss, Germany) 
under inverted microscopes (Eclipse Ti, Nikon, Japan). All reagents for cell 
differentiation and staining were obtained from Sigma-Aldrich. 
9. Reverse transcription-polymerase chain reaction 
For reverse transcription-polymerase chain reaction (RT-PCR), total RNA 
was extracted from differentiated cell populations using Trizol® reagent (Life 
technologies, Carlsbad, CA). cDNA was synthesized from 1 μg/mL of total RNA 




PCR was performed using i-StarTaqTM DNA polymerase (Intron Biotechnology, 
Seongnam, Korea). Table 3 displays the primer pairs for differentiation markers and 
PCR reaction conditions (Yang et al., 2011; Kim et al., 2012; Park et al., 2012). The 
amplified PCR products were electrophoresed on 2% agarose gels containing 
ethidium bromide (Et-Br) and analyzed using ImageJ software.  
10. Image analysis and statistics  
As previously mentioned, all data are expressed as the mean ± SEM of at 
least three independent experiments. Statistical comparisons of the experimental 
results were determined by analysis of variance (ANOVA) followed by Tukey’s 















IV. Results  
1. hMSCs size distribution  
 As above mentioned, hMSCs are known as composed of heterogeneous 
populations with variable sizes. First of all, to verify this characterization of hMSCs, 
we investigated size distributions of hMSCs to confirm the size barriers and 
determined the number divided cell scale ratio in our study. From the cell images in 
cultured states, the longest length (Ll), the shortest length (Ls) and the area were 
analyzed using Image J and these parameter were compared to the literature data 
(Haasters et al., 2009) (Fig. 4a). Note that the size distribution at suspended state is 
meaningful information for the microfluidic chip filtration. As Fig. 4b, the 
equivalent diameter d (= l sL L ) of our hMSCs is ranging from 16 to 62 μm (ave. 
26.1 ± 2.1 μm) in suspended status. We determined their sizes into three groups: 
small (< 25 μm), medium (25-40 μm), and large (> 40 μm) one. The corresponding 
cumulative populations are estimated as 42, 47, and 11%. Therefore, we determined 
Wc for 12.5 μm (a half of small cell average diameter) and 20 μm (a half of medium 
average diameter) for outlet 1 and outlet 2, respectively in this chip.  
2. Side flow effects on focusing and flow fractionation 
Prior to all experiments, we performed like this are being calculated 
(theoretical value), the flow velocity of the fluid in the chip ensure that each outlet 
was designed by fractionation. In this experiment, Qt and running times were out 
coming flow volume in each outlet were measured and compared the ratios of 





Figure 4. The hMSCs size distribution. (a) Relationship between major axis and 2-
dimensional area of hMSCs in cultured state compared with previously published 
data, and (b) distribution of suspended hMSCs based on 2-dimensional area and its 




Considering the design, we predicted the theoretical flow distribution values 
and the output flow rate values demonstrated 92.49 % at outlet 1, 4.59 % and 2.92% 
at outlet 2 and outlet 3.  
We performed the flow fractionation of this microchip at variable Qt = 5, 30, 
and 100 μL but flow ratio was fixed at 6 (Qs:Qm). From the experiments (5 μL/min) 
we have got the flow fractionation ratio, 69.29 ± 1.1% at outlet 1, 16.75 ± 1.0% and 
13.95 ± 1.2% at outlet 2 and outlet 3. At Qt = 30 μL/min, the flow fractionation ratio 
were 87.14 ± 1.6% at outlet 1, 6.84 ± 0.6% and 4.96 ± 2.59% at outlet 2 and outlet 
3. In addition, At Qt  = 100 μL/min, the flow fractionation ratio were 86.85 ± 1.44% 
at outlet 1, 7.37 ± 0.19% and 5.76 ± 1.26% at outlet 2 and outlet 3.  
At the microchannel design stage it was assumed that the flow rate 
distribution in the horizontal (width) direction is parabolic as shown in Fig. 1 while 
the flow rate distribution in the vertical (depth) direction was neglected. 
Theoretically, it was estimated that percentages of the volumetric flow rate passing 
through each branch point will be split into a side channel, when the ratio of the 
flow rates from inlets 1, 2, and 3 is 1:1:0.2.  
The range of total flow rate (Qt) was conducted from 0.3 to 200 μL/min and 
that of ratio was conducted from 3 to 20, respectively (Fig. 5). Due to the flow rates 
of the two inlet and the flow ratio of the main and the side fluid (Qs/ Qm) were 
various fluids and dimensions of the inlet channels, when the two fluids “met” at 
the entrance of the main channel, the main fluid was pushed further towards the 
side walls, decreasing the width of the main fluid. At the entrance region, the main 




Figure 5. Flow distribution in the multibranched sorting chip. (a) Comparisons of 
calculated flow fractionation and experimental flow fractionations in various flow 
ratios. (b) Virtual cut-off widths with variations of Qt and Qs/Qm, which are 
determined from the fully-developed region between main and side channel node 




for Qs/Qm = 6 and Qt = 0.3 μL/min (upper) and strong focusing for Qs/Qm = 20 and 





entrance length, which is called width of Wc. The depth of Wc were observed by 
the inverted epi-microscope and the images were captured using sCMOS camera. 
The all image data was analyzed by the ImageJ (NIH, MD).  
3. Sorting of bidisperse spherical particles 
Before the cell size dependent separation, we first examined whether 
spherical rigid model particles behaviors would move toward one sidewall by flow 
splitting and diverts into the outlets relative to their size. Fig. 6a shows the streak 
imaging of particle behavior at the confluent points of the main channel and branch 
channels. Small particles with 15 μm diameter might go to the branch channel, 
whereas 39 μm particles, which are larger size, are passed along the main channel. 
It was therefore demonstrated that the particles with diameter larger than 39 μm 
moved toward one sidewall in the main channel after the split flows were 
recombined in the main channel. In fact, the theoretical value of Wc was 12.5 μm 
and the virtual values of Wc was 9.72 μm for the first 48 branches. It was suggested 
that particles with radius larger than Wc never go through the side channels. It was 
expected that spherical solid particles/cell with diameter larger than 2 × Wc would 
flow through the main channel but would not flow into the side channels.  
The images of sorted particles in each outlet are shown in Fig. 6b. As 
shown in the data, the small particles with 15 μm were mainly collected at outlet 1 
and larger ones with the 39 μm were found at outlet 2 and outlet 3 after separation. 
To evaluate the separation efficiency, particles collected from each outlet were 
analyzed using ImageJ, which were presented graphs of the purity and recovery rate 




Figure 6. Sorting results of the model particles using multibranched chip. (a) Streak 
images of large particle (39 μm) flowing in main channel and small one (15 μm) 
flowing in branch channel, where images were taken at the region between 4th and 
12th branch points, (b) The images of particles before sorting and particles from 
collected each outlets after sorting, and (c-d) the sorting efficiency represented 





collected through a particular outlet to the total number of target particles during 
sorting. The purity ratio is represented as the ratio of the number of target particles 
to total number of particles in a particular outlet (Jung et al., 2015). As shown in Fig. 
6c, 15 μm particles were found in outlet 1 only, represented recovery rate of 100%. 
While, 39 μm particles were collected through outlet 2 and outlet 3 at a recovery 
rate of 55% and 45%, respectively. Considering of purity ratio, 100% of the 15 μm 
particles went through the outlet 1, and 100% of the 39 μm went through outlet 2 
and outlet 3.  
4. Sorting of hMSCs subpopulation  
Regarding the movement of particles, Fig. 7a shows streak images of 
green fluorescent protein-labeled hMSCs along the branch channel during 
separation. Fig. 7b shows the distribution of hMSCs collected in each outlet. The 
average sizes of the cells were 17.2 ± 5.3 μm in outlet 1 and 28.8 ± 5.4 μm in outlet 
2. Also, cells 52 ± 13 μm or over 55 μm, which seemed to be aggregated, were 
observed in outlet 3. In this study, the aggregated cells were regarded as a single 
large cell and exited via Outlet 3. As predicted, small (< 25 μm), medium (25-40 
μm), and large (> 40 μm) cells were main founded in outlets 1, 2, and 3, 
respectively. The purity obtained using label-free microfluidic techniques ranges 
from about 60-99%. Our results show that sorting populations of small and large 
cells from hMSCs concentrates the population of hMSCs with high multipotency. 
We emphasized that our hMSC sorting data represents improved cell-sorting 
efficiency. 





Figure 7. Sorting results of hMSCs using multibranched chip. (a) Sorting 
performance of a large cell flowing in main channel and small one flowing in 
branch channel. (b) The images of hMSCs before sorting and subpopulations from 
collected each outlet after sorting, and (c-d) the sorting efficiency with recovery and 







cells ranging between 25 and 40 μm in size were recovered at a rate of 4.92%. 
However, few cells (> 40 μm in diameter) were found there. In addition, the purity 
of the cells collected at outlet 1 was 100%, which is one of the highest purities 
obtained from current label-free microfluidic sorting techniques (85% and 95%). In 
outlet 2, the medium cells were recovered at a rate of 80.4% and the smaller cells 
were recovered at a rate of 15%. In addition, the purity of the cells at outlet 2 was 
over 98.7%. The larger cells were not observed here. In contrast, large cells (> 40 
μm in diameter) were recovered at a rate of 85% in outlet 3. Moreover, the purity of 
the cells in outlet 3 was 84%. Interestingly, the purity and recovery of cells was 
slightly lower than that for particles. This may be due to the effects of cellular shape 
and deformability. Although the cell deformation is so weak in our HDF chip (Fig. 
8), the effect still could change their original shape and interfere with cell 
movements, which decrease the sorting efficiency. First, we considered ratio of the 
maximum to minimum diameters of hMSCs to predict cell shape (Fig. 9). In any 
rotated cells, it is possible to measure both Ll and Ls by applying the reasonable 
assumption of a 2D ellipsoid for the dimensions of the deformed cell. 
As shown Fig. 9a, the dotted lines (blue color) represent the compact 
equivalent sphere. A ratio closer to 1 equated to a sphere shape, whereas a ratio far 
from 1 indicated an ellipse shape. As Fig. 9b shows, the population of cells mainly 
factors such as cellular shape and deformability when sorting for a particular size. 
Recent studies on inertial separation focusing on non-spherical particles reported 
that the rotational diameter of particles, regardless of their cross-sectional shape, 
determines the final focused position, except in the case of asymmetric disks. Also, 




Figure 8. Deformability of hMSCs in the multibranched channel with different 
flow ratio. (a) Deformation index (DI) represented the change of cell shapes to 
different flow ratio (Qs:Qm = 10 and 6). (b) The relationship between change of 






Figure 9. Biophysical makers of hMSCs in suspended state. (a) Cell diameter 
assumed major axis (Ll) and minor axis (Ls) with rolling behavior. (b) The 





hardened cells.  
These studies displayed good agreement with our results that FL cells, 
which are more deformable than smaller cells, underwent fast lateral migration 
toward the center. These favorable results may not always occur when FLs 
(relatively large and hardened cells) are separated from small, RS and SS cells 
(relatively small but deformable cells). However, these issues must be studied in 
future works. 
5. Cell viability and growth of hMSCs subpopulation 
In this study, we proposed channel sorting via a sorting chip and HDF 
using only fluid and no chemical modification to achieve cell separation with 
minimal physical damage. Optical micrographs and viability results for the sorted 
hMSCs obtained from the outlets are shown in Fig. 10. Following separation, cell 
viability was assessed using trypan blue dye exclusion and was expressed as the 
percentage of viable cells (cells that excluded the dye) among the total cells 
collected from each outlet. As illustrated in Fig. 10a, the viabilities of the sorted 
subpopulations were 97%, 92%, and 90% from Outlets 1, 2, and 3 at 30 μL/min, 
respectively. These percentages are similar to the initial viability of hMSC cells and 
comparable to results previously reported (Yamada et al., 2007; Lee et al., 2011; 
Warkiani et al., 2014). The levels decreased slightly at 50 μL/min (95%, 91%, and 
87% from Outlets 1, 2, and 3, respectively), but the sorting process did not cause 
critical damage. Indeed, the large cells exhibited lower viability than the small and 
medium cells. This suggests that the effect of flow conditions on viability is 




Figure 10. Viability of cells before separation and after sorting process. (a) 
Viability of sorted cells from each outlet after sorting for different total flow rates 
and (b) comparison of growth rate between unsorted (initial) cells and accumulative 





Next, we compared the cell growth rate between the sorted subpopulations to 
determine the population with the highest rate of self-renewal. The same number of 
sorted cells from each outlet were seeded, and then the total number of cells were 
counted at the indicated times. On the basis of doubling time (tD), we found that 
small cells collected from Outlet 1 grew faster than the others (cf., 57.4, 69.1, and 
100.9 hr for each cell ), as presented in Fig. 10b. The tD was calculated as follows: 
tD = t[ln 2/ln (Nf/Nb)],    (16) 
where Nb was the cell number at the beginning of the incubation time, and Nf was 
the cell number at the end of the incubation time. 
6. Expression of surface markers in the sorted subpopulations 
Generally, hMSCs would be defined by the specific surface marker 
expressions as one of the minimal criteria (Dominici et al., 2006). In previous study, 
among the hMSCs populations, the small and rapid self-renewing cells expressed 
CD73, CD90, and CD105 simultaneously, while large flattened cells showed a loss 
of one or more hMSC surface markers, mainly lack of CD73 expression (Hassters 
et al., 2009). Thus, we would determine whether our sorting populations could be 
represented to them in previous reports.  
According to Fig. 11a, the small rounded cells collected from outlet 1 
expressed CD73 and CD90 together, representing that they were RS-like cells. The 
medium-sized outlet 2 cells with spindle-shaped also showed both CD73 and CD90 
expressions, indicating they were SS-like cells. On the other hand, the large cells 




Figure 11. Morphological and immunochemical characterizations of hMSC 
subpopulations. The images show the maximum diameter and area with the 





cells. Additionally, in Fig. 11b, the cells from outlet 1 show high level of CD73 and 
CD105 together, but the cells from outlet 3 did not find CD73 expression. We 
analyzed and summarized the expression levels of each population in Table 4. In 
Table 4, all the cells from outlet 1 were double expressions for CD73/CD90, 
whereas most cells from outlet 3 (84.4%) show CD 90 expressions without CD 73.  
Likewise, similar results were obtained with double immunocytochemistry 
of CD73/CD105. All the cells from outlet 1 were double positive, whereas most 
cells from outlet 3 (91.7%) were single positive for CD105. We also measured the 
maximum diameter and the area of cells from each outlet and compared with the 
previous data. Our results are consistent with the previous report that the maximum 
diameter of RS cells is less than 157 μm and the area is smaller than 6617 μm2, 
while FL cells have a larger maximum diameter (> 157 μm) and a larger area (> 
6617 μm2). The previous report presented the correlation between the 
morphological characteristic of each subpopulation of hMSCs and the expression 
patterns of surface markers. 
These data demonstrated that sorting hMSCs using microfluidic chip 
filtration can successfully fractionate into the three subpopulations RS, SS, and FL 
cells, respectively. 
7. Differentiation of hMSCs subpopulations  
Several studies have shown that the cell cycle of hMSCs is correlated with 
a small and highly proliferative subpopulation of hMSCs; smaller hMSCs exhibit 








No. of cells (%) 
Outlet 1 Outlet 2 Outlet 3 
CD73(+)  
134 
0 (0) 3 (6.4) 0 (0) 
CD90(+)  0 (0) 3 (6.4) 27 (84.4) 
CD73(+)/CD90(+) 55 (100) 41 (87.2) 0 (0) 
CD73(−)/CD90(−) 0 (0) 0 (0) 5 (15.6) 
CD73(+) 
183 
0 (0) 3 (4.4) 0 (0) 
CD105(+) 0 (0) 3 (4.4) 44 (91.7) 
CD73(+)/CD105(+) 67 (100) 62 (91.2) 0 (0) 
CD73(−)/CD105(−) 0 (0) 0 (0) 4 (8.3) 
 






lineages via chemical induction relative to larger hMSCs (Colter et al., 2001; Lee et 
al., 2011). To verify the relationship between cell size and multipotency. we 
investigated the adipogenic, osteogenic, and Schwann cell (SC) differentiation 
potentials of the sorted populations, and compared the morphologic changes 
among subpopulations during differentiation. Thus, following size-based sorting, 
the subpopulations were subjected to the induction procedures, and compared with 
the unsorted and non-induction groups as the controls.  
After adipogenic differentiation, no morphological differences were 
observed among the sorted populations under a bright-field microscope for the first 
2 days. On the third day, lipid droplets (black spots in the figures) were apparent in 
the RS and SS populations, but not in the FL or the control populations (Fig. 12a). 
These black spots were confirmed to be lipid droplets at high magnification (data 
not shown). On the seventh day, the number and size of droplets in both 
subpopulation groups had increased considerably relative to Day 3. Some lipid 
droplets were found in unsorted cells, but these were detected less than in RS and 
SS cells. Lipid-droplet formation in FL cells was comparable to that in the non-
induction group.  
After osteogenic differentiation, several studies have reported that cells 
become flat and spread in multiple directions in two dimensions compared with the 
fibroblast-like spindle shape of the control cells (Matsuoka, 2013). Likewise, in our 
data, it was difficult to detect morphologic changes in cells during osteogenic 
differentiation because the cells appeared very thin and flat under the bright-field 
microscope. Thus, we performed ALP staining of the subpopulations and the 




morphologic changes were observed. However, from the third day, induction group 
cells were flat and spread out, whereas the control cells were compact and dense. 
Moreover, as expected, ALP activity was significantly higher in RS and SS cells 
than in unsorted and FL cells (Fig. 12b). First, we stained the subpopulations that 
had undergone adipogenic differentiation with Oil Red O. Induction was apparent 
by the accumulation of lipid-rich vacuoles within the cells, which continued to 
develop over time, coalesced, and eventually filled the cells (Pittenger et al., 1999). 
As shown in Fig. 13a, RS and SS populations had many more lipid droplets with 
red color along the cell edges than unsorted and the control cells. Moreover, the 
number of lipid droplets in RS and SS cells was much higher than that in FL and 
the control cells. Although the observed morphologic differences may be related to 
differentiation, they are insufficient to quantitatively predict the final cellular state 
(Matsuoka, 2013). Thus, the adipogenic character of the sorted populations was 
evaluated by performing functional and genetic assays. In adipogenic 
differentiation, a complex series of changes involving the expression of specific 
genes occurs. Stem cell differentiation is characterized by growth arrest, followed 
by the induction and expression of multiple adipogenic genes and, ultimately, 
triglyceride accumulation. Peroxisome proliferator-activated receptor gamma 2 
(PPARγ2), lipoprotein lipase (LPL), aP2, and adiponectin are key regulators of 
adipocyte differentiation. PPARγ2 is a transcription factor expressed at high levels 
by adipocytes during the early stages of adipogenic differentiation (Tontonoz et al., 
1994; Cristancho & Lazar, 2011). LPL is an enzyme that the controls lipid 
accumulation that is induced by insulin and troglitazone during adipogenic 




Figure 12. Morphological changes in sorted populations during adipogenic and 
osteogenic differentiations. The sorted populations were cultured in (a) aidipogenic 




were observed. The non-differentiation induction populations and unsorted 






binding protein 4 (FABP4), is a carrier protein for fatty acids and has been 
extensively used as a marker for differentiated adipocytes (Baxa CA et al., 1989). 
Adiponectin is secreted protein from adipocytes and has a role in modulating 
glucose regulation and fatty acid oxidation (Yamauchi et al., 2001). We examined 
the expressions of these adipogenic markers using semi- quantitative RT–PCR 
analysis. As shown in Fig. 13b, PPARγ2 expression in the RS and SS populations 
was 3- and 2.5-fold higher than in the unsorted group, respectively, and six- and 
fivefold higher than in the FL group, respectively. LPL expression in the RS and SS 
populations was 1.8 and 1.7-fold higher than in the unsorted group, and 7.5 and 7.2 
fold higher than in the FL group, respectively. The expression of aP2 in the RS and 
SS populations was higher than the FL groups (1.3 times) but comparable to the 
unsorted groups. Additionally, the adiponectin level in RS was higher than in the 
unsorted group and SS group and significantly higher than in the FL group, 
respectively. These results indicated that the differentiation potential of RS and SS 
cells was indistinguishable. These results indicate that RS and SS groups have 
higher adipogenic differentiation potential than the unsorted population because of 
the removal of FL cells with lower differentiation potential.  
Under osteogenic differentiation conditions, the populations showed 
remarkably different levels of ALP activity despite no significant morphologic 
differences, as shown in Fig. 14a. The RS and SS groups exhibited considerably 
higher ALP activity than unsorted cells or the LF population, but the control group 
did not exhibit mineralization under basal in-vitro culture conditions. Next, the 
relative expression levels of osteogenesis-related genes, namely Runt-related 




Figure 13. Comparison of adipogenic marker gene expressions in sorted 
subpopulations. Using the semi-quantities RT-PCR, the expression of markers for 
adipogenesis (PPARγ2, LPL, aP2, and adiponectin) were analyzed. There data were 
normalized to glyceraldehyde-3-phosphte dehydrogenase (GAPDH) and their 
relative expression was calculated. The bars represent mean ± SEM of at least three 
independent experiments. ***P < 0.001, **P < 0.01, *P < 0.05 versus the control 
hMSCs. ††P < 0.01, †P < 0.05 versus unsorted hMSC and ###P < 0.001, ##P < 0.01 





homeobox homologue 2 (MSX2), were quantified using semi-quantitative RT–
PCR analysis. RUNX2 is a key transcription factor and a central regulator of bone 
formation, which mediates osteoblast-specific target genes, such as OCN during 
osteoblast differentiation (Ducy et al., 1997, Byun et al., 2012). OPN is a 
matricellular protein that predominantly expressed in bone by osteoblast and 
controlled by transcription factors, such as RUNX2 and osterix (OSX) (Kim et al., 
2012). OCN is a bone-specific protein synthesized by osteoblasts and secreted into 
conditioned media at early stages of osteogenesis (Nakamura et al., 2009). MSX2 is 
a homeodomain transcription factor that acts upstream of RUNX2, which enhances 
osteogenesis (Cheng et al., 2003; Kim et al., 2012). Expressions of these genes 
indicate mineralization, which reflects the osteogenic potential of cells. Fig. 14b 
shows that OCN expression was 1.5 and 1.4 times higher in RS and SS cells than in 
the unsorted group, respectively, and four- and fourfold higher in RS and SS cells 
than in FL cells, respectively. Similarly, MSX2 expression in the RS and SS groups 
was three- and 2.5-times higher, respectively, than in the unsorted group. Moreover, 
MSX2 expression in the RS and SS groups was at least six and five times higher, 
respectively, than in FL cells, similarly to the control groups. However, the 
differentiation potential was indistinguishable between RS and SS cells.  
Together, RS and SS groups consist of the cells with differentiation 
potential, whereas FL cells exhibit a low differentiation potential similar to that of 
the control groups. Interestingly, the unsorted group exhibited potential, but this 
would be lower than that of RS and SS groups because of the presence of FL cells 
in the unsorted population. Therefore, the sorted subpopulations have different 




Figure 14. Comparison of osteogenic marker gene expressions in sorted 
subpopulations. Using the semi-quantities RT-PCR, the expression of markers for 
osteogenesis (RUNX2, MSX2, OPN, and OCN) were analyzed. There data were 
normalized to glyceraldehyde-3-phosphte dehydrogenase (GAPDH) and their 
relative expression was calculated. The bars represent mean ± SEM of at least three 
independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001 versus the control 
hMSCs. †P < 0.05 ††P < 0.01, †††P < 0.01, versus unsorted hMSCs. ###P 0.001 





differentiation potentials than the FL population.  
To verify the multipotency of these stem cells, the sorted subpopulations 
were subjected to the induction of Schwann cell (SC) differentiation. SCs are the 
principal glia of the peripheral nervous system (PNS), and function to support 
neurons and encircle the axons of motor and sensory neurons to form the myelin 
sheath. SCs are involved in the conduction of nervous impulses along axons, 
nervous development and regeneration, trophic support for neurons, production of 
the nerve extracellular matrix, and modulation of neuromuscular synaptic activity. 
Specifically, SCs are known for their roles in supporting nerve regeneration, 
because nerves in the PNS consist of many axons myelinated by SCs. SCs can 
guide regeneration by forming mesenchymal stem cells, acts to stimulate 
mitogenesis, cell motility, and matrix invasion, giving it a central role in 
angiogenesis, tumorigenesis, and tissue, a type of tunnel that leads toward the target 
neurons.  
There are many reports that hMSCs have the potential to transdifferentiate 
into neuron-like cells, exhibiting various neuronal markers and functional 
neuroactivity, in addition to multiple mesodermal cell types (Sanchez-Ramos et al., 
2000; Woodbury et al., 2000; Trzaska et al., 2007;). To determine the status of the 
SC-induced cells, we examined mRNA levels of the SC-specific markers, Glial 
fibrillary acidic protein (GFAP), S100, and P0 using RT–PCR (Fig. 15). GFAP is 
an intermediate filament and a major component of the astrocyte cytoskeleton. The 
S100 protein is a calcium-binding protein that is expressed in astrocytes and SCs. It 
stimulates cell proliferation and migration while inhibiting apoptosis and 




Figure 15. Comparison of Schwann cell marker gene expressions in sorted 
subpopulations. Using the semi-quantities RT-PCR, the expression of markers 
(GFAP, P0, and S100) and growth factors (HGF and VEGF) were analyzed. There 
data were normalized to glyceraldehyde-3-phosphte dehydrogenase (GAPDH) and 
their relative expression was calculated. The bars represent mean ± SEM of at least 
three independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001 versus the 
control hMSCs. ††P < 0.01, †††P < 0.001 versus unsorted hMSC cells. §P < 0.05, 









component of myelin that promotes adhesion between myelin membranes, thus 
helping PNS myelin compaction. As shown in Fig. 15b, GFAP expression by 
hMSCs is maintained in all non-induced and induced groups, but in FL cells, it was 
decreased 0.6-fold compared with the control group (Figs. 15b and c). Also, P0 
expression by sorted hMSCs was increased in unsorted, RS, and SS cells compared 
with the control cells. Although P0 expression in FL cells was lower than in the 
other groups, its expression was highly sustained compared with the control cells 
(Figs. 15b and d). S100 levels were highly maintained in the induction groups and 
did not show significant differences among the cell groups, including the non-
induced group (Figs. 15b and e). These results suggest that RS and SS groups may 
exhibit multipotency, and that they successfully differentiated into SCs. As 
mentioned earlier, SCs secrete specific growth factors, particularly the paracrine 
factors HGF and VEGF. HGF, a paracrine cellular growth factor secreted by 
regeneration. VEGF is one of the most important growth and survival factors: it 
induces angiogenesis and endothelial cell proliferation, and it plays an important 
role in regulating vasculogenesis. These proteins are reportedly secreted by SCs and 
exert paracrine effects during tissue injury to stimulate nerve regeneration. We 
examined whether the sorted subpopulations differentiated into compact SCs and 
secreted these growth factors, and compared them with the control and unsorted 
populations. 
As shown (Figs. 15b and f), HGF expression increased by around 1.2–1.4 
fold in the unsorted group compared with the control population, but its level in FL 
cells was a little lower than in the other populations. The levels of VEGF in the 




and FL cells exhibited basal levels similar to the control groups (Figs. 15b and g). 
These data suggest that the sorted RS and SS cells may have differentiated into SCs 




V. Discussion  
Stem cells are defined as cells capable of continued self-renewal through 
replication and are the precursor cells of specific tissue types. Stem cells have been 
used to successfully replace dead cells and cells lost through degenerative diseases 
and to repair damaged tissue. Stem cells have a wide range of practical applications, 
including bone healing, repair of suspensory ligament tears and nerve injury, as 
well as inflammatory relief during arthritis and immune suppression in the context 
of graft rejection (Korbling and Estrov, 2003; Uccelli et al., 2008; Ertl et al., 2014). 
However, the utility of hMSCs is becoming increasingly unclear because of the 
recent finding of heterogeneous populations with different levels of stemness within 
hMSCs isolated by traditional plastic adherence (Lv et al., 2014). Furthermore, 
during long-term expansion post-isolation, stem cells may differentiate into 
undesired cell types, which results in a heterogeneous mixture and affects their 
suitability for transplantation. Therefore, the separation of target stem cells with 
high potential from other groups is very important for stem cell-based therapies and 
research. In this study, we used an HDF-based microfluidic chip that we designed 
previously to sort hMSCs into three subpopulations based on size (Jung et al., 2015). 
The sorted subpopulations showed conspicuous differences in size and viability, as 
well as different potentials. The RS and SS populations exhibited significantly 
higher differential potential than unsorted cells and FL cells during adipogenic and 
osteogenic differentiation. These results suggest that RS and SS groups possess 
greater differentiation potential than the unsorted populations because of the 




multibranched chip successfully sorted hMSCs based on size and that cell size is 
closely related to multipotency and can serve as an indicator of differential potential. 
Although the size-dependent sorting of hMSCs was successful, cell size 
alone cannot be used to determine a cell’s differentiation potential. There have been 
many studies of the effects of factors such as stiffness, the nuclear fraction of cells, 
and cell deformation on the multipotency of stem cells (Lee et al., 2014b). However, 
cell-size changes, in addition to limiting the physical characteristics of cells, are 
likely to affect cell proliferation and differentiation as well as other functions in the 
cellular environment. FL cells have been reported to be early osteoprogenitors and 
exhibit more osteogenic characteristics than small cells (Haasters et al., 2009; Poon 
et al., 2015). However, in our study, FL cells were obtained at a higher passage 
number (passage 17) and larger size (average 40 ± 5.1 μm) than in previous studies 
(average size > 21.9 ± 5.3 μm), and ALP staining levels in FL cells did not increase 
according to osteogenic differentiation. This suggests that FL cells lose their 
differentiation ability through cell cycle exit (Despars et al., 2013). 
Although RS and SS subpopulations were different in size, their 
differentiation potentials and sorting efficiencies were very similar. To determine if 
there were significant differences between the RS and SS groups in biological 
characteristics other than size, the current chip design could be modified. Larger 
cells may have more irregular (elliptical) shapes than smaller cells. This suggests 
that cells with a non-round shape may have different cutoff widths, leading them to 
irrelevant outlets. This may reduce sorting efficiency. An advanced chip model 
should consider shape as well as size for an additional filtering effect. In addition, 




chip. In such cases, abnormal cell groups would flow through the multibranched 
channels based on cell-diameter criteria, and would be discharged to outlets 
designed for larger-diameter cells. It is essential that these abnormal cells be sorted 
into smaller subgroups, because the subpopulations may be resuspended to seed 
long-term cultures. To prevent this problem, we could attempt to add a stirring 
system to the sorting chip to reduce cell sedimentation and aggregation and the 
secondary structure could be located at the front area of the main channel. For 
individual cells, we would expect a secondary filtering effect due to shape in 
addition to size. 
Several studies have reported separation of hMSCs based on physical 
characteristics including cell size. However, most used hMSCs at an early passage 
number (< Passages 5-10), when the differentiation potentials of the various 
subpopulations are comparable (Khoo et al., 2008; Byun et al., 2012; Poon et al., 
2015). Several reports on the extensive subcultivation of hMSCs described changes 
in morphology, proliferation, telomere length, and mesodermal differentiation 
capacity. In particular, although hMSCs retain osteogenic differentiation potential 
through 10-15 passages, adipogenic potential is lost. In addition, spontaneous 
osteogenic differentiation with the deposition of minerals is observed in some 
cultures (DiGirolamo et al., 1999; Khoo et al., 2008). In this study, our purpose was 
to acquire target subpopulations enriched with cells with stem cell characteristics. 
Thus, we used high-passage number hMSCs to harvest enriched cell populations 
with high differentiation potentials. Our data suggest that the sorting microfluidic 
chip described here can be used to filter hMSCs of a broad range of passage 




 In conclusion, we acquired target subpopulations enriched with cells with 
stem cell characteristics from hMSCs using optimally designed microfluidic chip 
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신경성장인자(neurotrophin)는 척추동물의 신경계 발생과정 중 
신경세포의 생존과 분화를 결정짓는 인자로서 발생신경학 뿐만 아니라 
퇴행성 신경질환 및 정신 질환 등 여러 분야에서 그 작용에 대한 연구가 
활발하게 진행되어 왔다. 신경성장인자의 세포내 신호는 신경성장인자 
수용기와 결합하여 전달되는데, 이들 수용기와 상호작용하는 매개(adaptor) 
단백질에 의해 신호전달의 결과가 결정된다.  
 Ankyrin repeat-rich membrane spanning scaffold protein 
(ARMS)는 11개의 ankyrin repeats와 4개의 transmembrane 도메인, 
PDZ binding motif, sterile alpha motif (SAM) 도메인과 polyproline 
도메인을 가지고 있으며, protein kinase D의 기질(Kidins220)로도 알려져 
있다. 최근 보고된 연구결과를 통해 ARMS/Kidins220은 CrkL-G3G 
복합체를 통해 mitogen-activated protein kinase (MAPK)의 신호를 
비정상적으로 높이는 것으로 밝혀졌고, 특히 흑색종(melanoma)에서 
발현양이 크게 상승했음이 알려졌다. 이것은 ARMS가 잠재적으로 
암유발인자로서 작용할 가능성을 보여준 것으로 세포주기를 조절하는 
역할에 대한 연구의 필요성을 인식하게 되었다.  
 본 연구에서는 ARMS 의 신경아세포종(neuroblastoma)의 
세포주기(cell cycle)을 조절하는 단백질의 발현과 관련한 기능을 밝혔다. 
ARMS 의 발현감소는 세포의 성장률을 크게 감소시켰고 이것은 세포주기 
중 G1 단계를 조절하는 cyclin D1 과 CDK4 의 발현 감소에 의한 것임을 
확인하였다. 반면에 다른 주기의 조절 단백질인 cyclin A, cyclin E 혹은 




cyclin D1 과 CDK4 의 억제 인자인 p21 의 발현 증가에 따른 pRb 의 
과인산화 (hyperphosphorylation)가 유의적으로 감소됨을 확인하였다.  
우리는 이 연구를 통해 ARMS 가 세포주기를 조절하는 역할이 
있음으로 확인하였고, 이것은 세포주기 중 G1 단계의 cyclin D1/CDK4/ 
p21 의 발현 변화에 따른 신호전달에 의한 것임을 밝힘으로써 신경계질환 
이외 암연구에 있어서 새로운 조절인자로서의 가능성을 제시하게 되었다.  
사람 골수 유래 중간엽 줄기세포(hMSC)는 많은 성체 조직에 
존재하면서 자가증식(self-renewal)이 가능하고 다양한 세포로 분화될 수 
있는 분화능(multipotency)을 가진 세포이다. 따라서 이 세포의 특성을 
연구하여 조직공학(tissue engineering)과 세포치료(cell therapy) 등에 
적용하고자 많은 연구가 진행되어 왔다. 그러나 실제 hMSCs 는 체내 
획득률이 낮고 다양한 크기의 세포로 이뤄져 있고, 각 세포군간 분화능의 
차이가 있는 것으로 보고 되었다. 따라서 보다 높은 분화능을 가진 
세포군을 분리하려는 많은 시도가 현재까지의 세포분리는 유세포분석기 
(FACS)나 자기활성세포분석기 (MACS)와 같은 고가의 장비와 이를 
운용할 수 있는 훈련된 인력이 필요하고 분리시 고가의 항체를 
사용함으로써 실험방법에 있어 상당한 시간과 경비가 소모되어 왔다. 이에 
본 연구에서는 이러한 단점을 보완하고 효율을 극대화 할 수 있는 방법으로 
미세유체칩(microfluidic chip)을 제안하였다. 또한 분리시 세포의 
손상(damage)이나 조작(modification)없이 본래의 상태를 유지하는데 
최적인 유체역학적 여과(hydrodynamic filtration, HDF)의 원리를 
적용하여 세포 크기별 분리 가능성을 검증하였다.  
본 연구에서 제작된 미세유체 세포 분리칩(cell sorting chip)은 




주채널의 다른 측면에 55 개의 다중가지 채널이 연결되어 있다. 이 
다중가지 채널은 세개의 배출구로 연결되며, 세포의 크기에 따라 세 
그룹으로 분리되도록 설계되었다. 즉 hMSCs는 미세 유체 세포 분리칩을 
통해 크기에 따라 RS (rapidly self-renewal cells, < 25 μm) 세포군, SS 
(spindle shaped cells, 25-40 μm) 세포군, 그리고 보다 크고 평평한 
모양의 FL (large, flattened cells, >40 μm) 세포군으로 분리되었고 
분리효율은 지금까지 타 연구결과 보다 높은 86% 임을 확인하였다. 각 
분리군의 성장속도, 표지 마커의 발현 및 분화 효율을 분석한 결과 RS 
세포와 SS 세포가 FL 세포에 비해 성장속도가 빠르고, 표지 마커 (CD73, 
CD90, CD105)가 모두 발현됨을 확인하였다. 또한 분리된 각 세포군을 
지방세포(adipocyte), 뼈세포(osteoblast), 슈반세포(Schwann cell)로 
분화시켰을때, RS 세포군와 SS 세포군이 FL세포에 비해 분화률이 현저히 
높음을 확인하였다.  
결론적으로 우리는 최적화된 미세유체 분리칩을 사용하여 각기 다른 
분화능을 가진 중간엽줄기세포 중 분화능이 높은 세포를 효과적으로 
분리했고, 이 방법에 통해 세포치료의 효율을 증가시킬 수 있는 분리법을 
개발했다는데 의의가 있다.  
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